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ABSTRACT
Aberrant activation of macrophages during inflammation results in oxidative
burst release of reactive oxygen and reactive nitrogen species (ROS/RNS) which
are widely accepted to participate in pathogenesis of cancer, cardiovascular
disease, atherosclerosis, hypertension, ischemia/reperfusion injury, diabetes
mellitus, neurodegenerative diseases (Alzheimer’s disease and Parkinson’s
disease), rheumatoid arthritis, and ageing. It is demonstrated here that Didox
(3,4-Dihydroxybenzohydroxamic

acid)

possesses

antioxidative

and

anti-

inflammatory properties that can protect against inflammation and oxidative
stress induced by lipopolysaccharide (LPS) and aryl hydrocarbon receptor (AHR)
ligands (PCB126, E804, and IO) in Raw 264.7 murine macrophages. In brief, it is
demonstrated here that Didox inhibits LPS-induced oxidative stress, ROS/RNS
generations, IL-6 production, NO production, phagocytic activity, and NF-κB
nuclear translocation in Raw 264.7 murine macrophages. Furthermore, Didox
downregulated ROS production, cytochrome P450 1A1 (CYP1A1), and AHR
nuclear translocation induced by PCB126, E804, and IO in Raw 264.7 murine
macrophages. These data suggest that oxidative stress regulatory effects of
Didox may be useful in managing inflammatory diseases conditions initiated by
exposure to AHR activating xenobiotics or LPS.
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CHAPTER 1: LITERATURE REVIEW

1.1 Inflammation and Oxidative stress
Inflammation is a complex stereotypical response of the damage to the body
cells and vascularized tissues. The inflammatory response is phylogenetically
and ontogenetically the oldest defense mechanism that is controlled by
cytokines, products of the plasma enzyme systems, lipid mediators released from
different cells, and by vasoactive mediators released from mast cells, basophils,
platelets and macrophages (Ross et al., 2002). Inflammation is the complex
immunological response of vascular tissues to exogenous or endogenous
harmful stimuli, such as pathogens, damaged cells, or irritants. It is a protective
attempt by the immune system to remove the injurious agents as well as initiate
the healing process for tissues.

When inflammation is lacking, wounds and infections persist and never heal
while progressive destruction of body tissue continue to compromise the survival
of the organism. However, aberrant inflammation can also lead to a host of
diseases, such as atherosclerosis, cancer, respiratory syndromes, multiple organ
dysfunction and rheumatoid arthritis (Fig 1.1, below). It is for that reason that
inflammation is normally closely regulated by the body. Inflammation can be
classified as either acute or chronic according to duration of response (Khansari
et al., 2009).
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Acute inflammation is the relatively shorter initial response of the body to harmful
stimuli and is achieved by the increased movement of plasma and leukocytes
from the blood into the site of injury or infection. It is a short-term process, usually
appearing in a few minutes or hours and ceasing once the injurious stimulus has
been removed. It is characterized by five cardinal signs: rubor (redness), calor
(increased heat), tumor (swelling), dolor (pain), and functio laesa (loss of
function). Recruitment of leukoctyes and production of various mediators trigger a
cascade of biochemical events which propagates and matures the inflammatory
response, involving the local vascular system, the immune system, and various
cells within the injured tissue. Prolonged inflammation, known as chronic
inflammation, leads to a progressive shift in the type of cells which are present at
the site of inflammation and is characterised by a lengthy simultaneous
destruction and healing of the tissue from the inflammatory process (FerreroMiliani et al., 2007).
Chronic inflammation is a pathological condition characterized by continued
active inflammation response and tissue destruction. Many of the immune cells
including macrophages, neutrophils and eosinophils are involved directly or by
production of inflammatory cytokines in pathology of chronic inflammation.
Chronic inflammation can be a major cause of cancers and neurodenegerative
diseases. Moreover, many studies suggest that chronic inflammation could play a
serious role in wide variety of age-related diseases including diabetes,
cardiovascular and autoimmune diseases. Inflammatory processes induce
oxidative stress and reduce cellular antioxidant capacity (Khansari et al., 2009).

2

Rheumatoid Arthritis

Figure 1.1 Consequences of aberrant inflammation and oxidative stress in
physiology. Oxidative stress and chronic inflammation can lead to a wide variety
disease conditions in multiple organs, rendering the usually protective immune reaction
a liability rather than an asset.

Overproduced free radicals react with cell membrane fatty acids and proteins
impairing their function permanently. In addition, free radicals can lead to
mutation and DNA damage that can be a predisposing factor for cancer and agerelated disorders (Khansari et al., 2009).
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The generation of reactive oxygen species (ROS) and other free radicals during
metabolism is a necessary and normal process that ideally is compensated for by
an elaborate endogenous antioxidant system. However, due to many
environmental, lifestyle, and pathological situations, excess radicals can
accumulate, resulting in oxidative stress (Figure 2). Oxidative stress has been
related to cardiovascular disease, cancer, and other chronic diseases that
account for a major portion of deaths today. Antioxidants are compounds that
hinder the oxidative processes and thereby delay or prevent oxidative stress
(Khansari et al., 2009).

1.1 (a) Reactive Oxygen intermediates and oxidative stress
Reactive oxygen species (ROS) are a cluster of highly unstable compounds that
are generated during inflammation and normal cellular metabolism via
incomplete reduction of molecular oxygen. They consist of molecules with
unpaired electrons such as superoxide anions (O2− ) and hydroxyl radical ( OH),
and molecules that have oxidizing propensity but do not possess free electrons,
for example hydrogen peroxide (H2O2) and hypochlorous acid (HOCl) (Abid et al.,
2005) . These species are involved in the regulation of fundamental cellular
activities such as cell growth and differentiation (Dor and Porat, 2001; D'Angio
and Maniscalco, 2002, Hopf et al., 2005 , and Veal et al., 2007). However, their
overproduction and/or the presence of impaired antioxidant ability results in
oxidative stress which can induce and propagate significant injury (Fig 1.2).

4

Likewise, reactive nitrogen species (RNS), the by-products of nitric oxide (NO)
metabolism, play an important role in maintaining various physiological functions
at basal levels, and contribute to several pathological processes at high levels.
Examples of RNS include nitrite (NO2-), nitrate (NO3−) and peroxynitrite (ONOO−)

Figure 1.2: Antioxidants and reactive oxygen species (ROS) exist in physiological
balance and are required for normal cellular function. Excessive generation of free
radicals generation of free radicals such as OH•, NO, O2•, H2O2 and deficiency of
antioxidants can lead to oxidative stress whereas the reverse leads to ROS deficiency.
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As these reactive oxygen and nitrogen species are deemed as second
messengers, it is important to note that they should have four basic
characteristics that allow regulation. (1) They are either enzymatically generated
or regulated by channels and pumps (2) They are enzymatically degraded. (3)
Their concentration rises and falls within a short period, and (4) They can be
specific in action (Boueiz and Hassoun, 2009).

1.1 (b) Reactive oxygen species
As divalent reduction of O2 to form H2O2 is spin restricted, one electron reduction
is favored and O2− is readily formed. Therefore, the major source of H2O2 in cells
arises from the dismutation of O2−. At physiological pH, non-enzymatic
dismutation is rapid, but dismutation is markedly accelerated by the superoxide
dismutases (SOD) to near the limit of diffusion. H2O2 can diffuse readily through
membranes, probably through the same channels as water. H2O2 is not a radical
and does not spontaneously react with carbon-centered molecules or thiols. It
does, however, react rapidly with thiolates (–S−) and transition metals. Hydroxyl
radical (OH•) can be generated when H2O2 collides with a reduced transition
metal, such as ferrous iron (Fe2++H2O2→Fe3++OH−+OH•) in a Fenton reaction.
The distribution of transition metals in the cell is generally well regulated and socalled free transition metals are associated with pathology rather than signaling.
The hydroxyl radical is so reactive that it will generally abstract a hydrogen from
the closest molecule, producing water and another radical. As damage to the
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molecule would probably ensue, it seems rather unlikely that OH• could act as a
second messenger. On the contrary, O2•− and H2O2 have all four of the
characteristics of second messengers as defined above, i.e. they are generated
enzymatically, degraded by SOD or catalase and glutathione peroxidases, are
present at very low concentrations but can transiently be elevated to measurable
amounts and both react only at specific sites, such as metals and thiolates
(Khansari et al., 2009).

1.1 (c) Reactive nitrogen species
The NO molecule itself has little chemical reactivity with organic molecules and
primarily binds to metals as in the regulatory site of guanylate cyclase and in
hemoglobin. In fact, guanylate cyclase has been shown to require NO binding to
its regulatory site in order to be active. Moreover, NO interacts with O2− to form
ONOO− , a reaction that is extremely fast (6.7×109 mol−1 s−1) and is determined
by the diffusion rate of NO, the relative amount of each radical, and their ability to
react with oxyHb for NO and SOD for O2−. Thus, this reaction can only occur in
localized areas close to the source of O2− release (Wink and Mitchell, 1998). The
peroxynitrite molecule is not itself highly reactive; however, its acid form,
peroxynitrous acid (ONOOH) is very unstable and reactive, having properties
similar to OH• and nitrogen dioxide (NO2). The formation of peroxynitrous acid is
thought to be the mechanism through which NO production can lead to toxicity
and the predominant mechanism of O2−-mediated toxicity when Fenton chemistry
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is not involved. It was widely assumed that ONOO− was destroyed through nonenzymatic degradation until recent studies suggested that glutathione peroxidase
could catalyze the reduction of ONOO− to NO2− (Sies and Arteel, 2000). That an
enzymatic mechanism appears to exist for its elimination is consistent with a role
for ONOO− as a second messenger. Peroxynitrite can interact with the cysteine
residues of proteins or glutathione, resulting in formation of S-nitrosothiols and
providing both a mechanism for regulation of thiol-dependent enzymatic activities
and a source of bioavailable NO that can be exchanged between thiols.
Peroxynitrite also modifies tyrosine residues, producing 3-nitrotyrosine (3NT).
While thought to be an irreversible process associated with injury, tyrosine
nitration may have a signaling role and be enzymatically reversed. Perhaps like
H2O2, ONOO− participates in signaling processes at low concentrations but, at
greater concentrations, produces toxicity (Boueiz and Hassoun, 2009).

1.1 (d) Antioxidant defense and redox signaling
The production of reactive oxygen and nitrogen species is a steady-state event in
respiring cells, and uncontrolled production of these reactive species is the
primary cause of some major degenerative conditions. Cellular defense, targeted
against these transient but damaging species, can be grouped under several
mechanisms, and collectively they operate to terminate free radical reactions or
remove reactive species and their secondary products. Since oxygen and
nitrogen atoms of reactive oxygen intermediates (ROI) contain unpaired
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electrons in their outer electron shells, they can react with other molecules to
restore their electron pairing. These could lead to damaging of biological
molecules such as nucleic acids, proteins, and lipids. To minimize heavy metal–
induced catalysis of the Fenton and Haber-Weiss reactions that generate the
most reactive hydroxyl radical, expression of several specific metal-binding
proteins such as haptoglobin, ceruloplasmin, ferritin, transferrin, lactoferrin, and
albumin, ensures that these metals remain cryptic, thereby serving as a key
preventive measure in the overall free radical defense system. Antioxidant
enzymes, most of which are highly dependent upon exogenous co-factors for
their activity, can dismutate superoxide anion (superoxide dismutase) directly into
hydrogen peroxide which in turn can be removed by catalase or several forms of
glutathione peroxidase.
Finally, direct quenching of radicals can be achieved by a series of endogenous
and exogenous antioxidants. Functioning as scavengers, these molecules donate
electrons, and themselves become free radicals that can either initiate chain
reactions or conversely, be regenerated. It is now known that active repair
pathways exist in which endogenous antioxidants such as glutathione, ubiquinol
and NADH/NADPH, are obligatory in the recycling pathways via redox reactions.
It has long been known that control of the intracellular redox environment is vital
for proper cellular function. To protect themselves from the constant oxidative
challenge, cells have developed defense mechanisms that insure the proper
balance between the prooxidant and antioxidant molecules. In addition to the
enzymes that remove ROS, such as SOD, catalase and glutathione peroxidase,
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glutathione (GSH/GSSG) and thioredoxin (Trx) systems are key players in the
maintenance of the redox status of the cells, defined as the ratio of the
concentration of oxidizing equivalents to that of reducing equivalents. Members
of the Trx family have a conserved catalytic site with two cysteine residues that
undergo reversible oxidation to form a disulfide bridge through the transferring of
reducing equivalent to a disulfide substrate. The Trx then reverts to the reduced
form through the action of Trx reductase, an NADPH flavoprotein. Similarly, the
GSH/GSSG ratio is controlled by glutathione reductase. Peroxiredoxins are
another class of enzymes that can reduce H2O2 using thiols (Rhee et al., 1999),
some using thioredoxin as a co-substrate and at least one using glutathione (
Chen et al., 2000).
The antioxidant enzymes play a significant role in protection against cell injury.
Nonetheless, these enzymes may also play an additional role in signaling by
counterbalancing the production of ROS/RNS. Indeed, one may think of a role for
glutathione peroxidase in decreasing H2O2 concentration as analogous to the
role of phosphodiesterase in decreasing cAMP concentration. In other words, the
antioxidant enzymes provide the turn-off component of redox signaling. The
interplay between ROS signaling and inflammation involves a complex cellular
network comprising vascular cells and inflammatory and immune cells. Among
them, macrophages have a unique central role and mediator of co-ordinated
cellular and intercellular inflammatory reactions.
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1.1 (e) Oxidative stress and NF-κ
κB signaling
The nuclear factor associated κB (NF-κB) transcription factor plays a major role
in coordinating innate and adaptative immunity, cellular proliferation, apoptosis
and development. Since the discovery in 1991 that NF-κB may be activated by
H2O2, several laboratories have put a considerable effort into dissecting the
molecular mechanisms underlying this activation. Whereas early studies
revealed an uncharacteristic mechanism of activation, leading to IκBα
phosphorylation independently of IκB kinase (IKK), recent findings suggest that
H2O2 activates NF-κB mainly through the classical IKK-dependent pathway. The
molecular mechanisms leading to IKK activation are, however, cell-type specific
and the description of the effect of other ROS and RNS on NF-κB activation
comes essential. Recent data also highlights the role of ROS in NF-κB activation
by proinflammatory cytokines (TNF-α and IL-1β) and lipopolysaccharide (LPS),
two major components of macrophages-mediated innate immunity (Gloire et al.,
2006).
The transcription factor NF-κB is crucial in a series of cellular processes, such as
inflammation, immunity, cell proliferation and apoptosis. It consists of homo- or
heterodimers of a group of five proteins, namely NF-κB1 (p50 and its precursor
p105), NF-κB2 (p52 and its precursor p100), p65/RelA, c-Rel and RelB. In the
resting state, NF-κB is sequestered in the cytoplasm of the cell through its tight
association with inhibitory proteins called IκBs, comprising IκBα, IκBβ, IκBγ, IκBε,
Bcl-3, p100 and p105. Upon cell stimulation, IκB proteins are rapidly
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phosphorylated and degraded by the proteasome, and the freed NF-κB
translocates into the nucleus to regulate the expression of multiple target genes
(Hayden and Ghosh, 2004).
The classical NF-κB-activating pathway is induced by a variety of mediators,
such as pro-inflammatory cytokines (TNFα, IL-1β) and LPS binding to Toll-like
receptors (mainly TLR4). Although these NF-κB inducers signal through different
receptors and adaptor proteins, they all converge to the activation of IκB-kinase
(IKK) complex, which includes the scaffold protein NF-κB essential modulator
(NEMO, also called IKKγ), IKKα and IKKβ kinases. Once activated by
phosphorylation, the IKK complex phosphorylates IκBα on Ser32 and Ser36,
which is subsequently ubiquitinated and degraded via the proteasome pathway.
The freed NF-κB then translocates into the nucleus where it activates the
transcription of target genes such as cytokines (eg. IL-6), chemokines, adhesion
molecules, inflammatory enzymes (e.g. iNOS) and apoptosis mediators (Bonizzi
and Karin, 2004).
Beside this classical activation, a novel NEMO-independent NF-κB-activating
pathway, important for secondary lymphoid organ development and homeostasis
and adaptive immunity, was described. It is induced by B-cell activating factor
(BAFF), lymphotoxin β (LTβ), CD40 ligand and human T cell leukemia (HTLV)
and Epstein-Barr (EBV) virus . The NEMO-independent NF-κB-activating
pathway enhances NF-κB inducing kinase (NIK)- and IKKα-dependent
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processing of p100 into p52, which binds DNA in association with its partners,
like RelB. These stimuli also activate the classical pathway (Gloire et al., 2006).

In 1991, Schreck et al. were the first to demonstrate that direct addition of H2O2
to the culture medium of a subclone of Jurkat cells (Jurkat JR) could activate NFκB (Schreck et al., 1991). Since this discovery, several laboratories have put
considerable efforts into dissecting the molecular mechanisms underlying this
activation. The results that came out of these studies suggest that NF-κB
activation by H2O2 is highly cell-type specific and involves quite different
mechanisms, making the role of H2O2 in macrophage signaling a subject of great
importance since they produce it in large amounts during inflammatory reactions.
Although the vast majority of studies concerning oxidant-induced NF-κB
activation have focussed on H2O2, other oxidants, like hypochlorous acid (HOCl)
and singlet oxygen (-O2), have been shown to modulate NF-κB activation. On the
other hand, some works have also highlighted NF-κB regulation by peroxinitrite
which is a reactive nitrogen species (Gloire et al., 2006).

To explain the diversity of inducers that activate NF-κB via the same IKKdependent pathway, a model has emerged suggesting that all NF-κB activators
cause an oxidative stress that is mainly responsible for IKK activation and IκBα
degradation. This model is based on several observations, including that most of
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NF-κB-inducers trigger the formation of ROS (Los et al., 1995) and that several
antioxidants can block NF-κB activation (Schreck et al., 1992). As a result of
research in these areas, the effects of different antioxidants (NAC, PDTC and
GSH) or over-expression of antioxidant enzymes (SOD) on NF-κB activation by
TNFα and IL-1β or LPS has been well documented. It will therefore be very
interesting to find out what effect ROS and RNS will have on activated
macrophages in searching for agents that can modulate macrophage activity.

1.2 Macrophages
Macrophages are key players in inflammation and their wide tissue distribution
makes them well suited to provide an immediate defense against foreign
elements prior to leukocyte migration (Zhang et al., 2008). Macrophages have
long been considered to be important immune effector cells. Élie Metchnikoff,
who won the Nobel Prize 100 years ago for his description of phagocytosis,
proposed that the key to immunity was to "stimulate the phagocytes" (Nathan,
2008). Since this discovery, immunologists have been occupied with the concept
of macrophages as immune effector cells and with understanding how these cells
participate in host defense. Macrophages are present in virtually all tissues. They
differentiate from circulating peripheral-blood mononuclear cells (PBMCs), which
migrate into tissue in the steady state or in response to inflammation. These
PBMCs develop from a common myeloid progenitor cell in the bone marrow that
is the precursor of many different cell types, including neutrophils, eosinophils,
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basophils, macrophages, dendritic cells (DCs) and mast cells. During monocyte
development, myeloid progenitor cells (termed granulocyte/macrophage colonyforming units) sequentially give rise to monoblasts, pro-monocytes and finally
monocytes, which are released from the bone marrow into the bloodstream.

Figure 1.3: Macrophages play a central in inflammation by interacting with other
inflammatory cells. Macrophages interact with neutrophils (NФ), dendritic cells (DC), B
cells and T cells (Th1/h2) to co-ordinate a successful immune attack in attempt to
remove the injurious stimuli. During chronic inflammation, macrophages release a
plethora of mediators which not only lead to direct tissue injury but also recruit far too
many iflammatory cells for prolonged period to a site of injury.
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Monocytes migrate from the blood into tissue to replenish long-lived tissuespecific macrophages of the bone (osteoclasts), alveoli, central nervous system
(microglial cells), connective tissue (histiocytes), gastrointestinal tract, liver
(Kupffer cells), spleen and peritoneum.

Macrophages play a pivotal role in innate and adaptive immunity by interacting
with other immunological and non-immunological cells to insure success of the
inflammatory process and clearance of invaders. As such, they play a central role
by interacting with cells such as neutrophils, dendritic cells, T cells, B cells,
Natural killer cells and fibroblasts (Fig 1.3). Concerning macrophage activation
and phagocytosis, large volumes of macrophage research have unraveled the
induction of cytokines such as IL-1β, IL-6, IL-10, TNF-α and transforming growth
factor (TGF); chemokines such as monocyte chemoattractant protein-1 (MCP-1)
and macrophage inflammatory protein-2 (MIP-2); the reactive oxygen species
(ROS), reactive nitrogen species (RNS) and nitric oxide (NO)-generated mainly
through iNOS.

During microbial contact, many parallel signaling pathways are simultaneously
activated

that

together

define

the

phagocyte

response

and

regulate

internalization of microbes by macrophages. Phagocytosis is a complex system
with special emphasis on four sources of that complexity. First, many different
receptors

recognize

microbes,

and

phagocytosis

is

usually

mediated

simultaneously by multiple receptors. Second, different microbe-recognition
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receptors induce different signaling pathways, and these signals interact
cooperatively (and sometimes destructively) to mediate ultimate responses to
particles. Third, microbe recognition is coupled (either directly through phagocytic
receptors or indirectly through co-receptors) to inflammatory responses that in
turn affect the efficiency of particle internalization by the phagocyte or
neighboring phagocytes. Fourth, many pathogenic microbes actively attempt to
regulate the mechanisms of phagocytosis to evade destruction. In this review we
have focused our discussion specifically on phagocytosis of microbes.
Phagocytosis also is required for normal clearance of apoptotic cells, a process
in which many of the same levels of complexity apply (Underhill and Ozinsky,
2002).

Particle internalization by macrophages is accompanied by activation of many
signaling pathways that together orchestrate rearrangement of the actin
cytoskeleton, extension of the plasma membrane, and engulfment. Dozens of
signaling molecules including actin binding proteins, membrane traffic regulators,
ion channels, kinases, and lipases are activated during phagocytosis of complex
particles (such as opsonized bacteria) and may contribute to efficient
internalization. Linking these proteins in a model of phagocytosis is a challenge,
and identifying the key regulators is a task that requires a concerted effort.
However, certain signaling molecules stand out both as participating in
phagocytosis

and

as

participating

in

many

other

signaling

pathways.

Phosphoinositide 3-kinase (PI 3-kinase), phospholipase C (PLC), Rho GTPases,
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and PKC are integration points for regulating of phagocytosis. Furthermore,
these molecules not only orchestrate the mechanics of particle ingestion, they
also regulate inflammatory responses and microbial killing (Underhill and
Ozinsky, 2002).

PI 3-kinase catalyzes phosphorylation of PI(4,5)P2 to PI(3,4,5)P3, a phospholipid
important in recruiting signaling molecules such as the kinase AKT/PKB to
specific regions of membranes. Pharmacological inhibition of PI 3-kinase blocks
phagocytosis of IgG- and complement-opsonized particles, unopsonized
zymosan, and bacteria, although the requirement may not be absolute because
the uptake of IgG-opsonized particles smaller than 3 microns across is less
affected than the uptake of larger. Inhibition of PI 3-kinase blocks membrane
extension and fusion behind the bound particle, perhaps due to a failure to insert
new membrane at the site of particle internalization (Cox et al., 1999).

In recent work using cells from knockout mice and microinjection of inhibitory
antibodies, Vieira and colleagues have demonstrated that these stages of
phagocytosis require class I PI 3-kinase, while a second type of PI 3-kinase,
class II/VPS34, is required for phagosome maturation (Vieira et al., 2001).

18

Phosphoinositide-specific phospholipase C (PI-PLC) mediates cleavage of PI (4,
5)P2 resulting in release of IP3 and DAG, second messengers that mobilize
intracellular Ca++ stores and activate protein kinase C family members,
respectively. PI-PLC is recruited to phagosomes containing IgG-opsonized
particles, and inhibition of its activity blocks particle internalization. Like protein
kinase C inhibitors, PLC inhibitors completely block the formation of actin
filaments beneath the site of particle contact, suggesting that the main role of
PLC in particle internalization is to activate protein kinase C (Botelho et al.,
2000). In addition to being required for the mechanical aspects of particle
internalization, PI 3-kinase and PI-PLC also are implicated in pro-inflammatory
signaling induced by particulate stimuli. Thus, PI 3-kinase is recruited to Toll-like
receptors when cells are stimulated with heat-killed S. aureus, and activation of
PI 3-kinase has been implicated in NF-κB-mediated cytokine production.
Similarly, PI-PLC activity is required for microbe-induced pro-inflammatory
signaling in macrophages primarily due to its role in activating PKC (Chen et al.,
2000).

Macrophages utilize phagocytic receptors and other pattern recognition
receptors, such as TLRs, to identify microbes and trigger immune defenses.
When microbes are engulfed my macrophages, TLR pathways activate the IL-1β
and inflammatory cytokine promoter, and the full repertoire of immune responses
is activated, and the IL-6 promoter and an NF-κB reporter are induced. Indeed,
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TLR pathways are vigorously activated by mycobacterial exposure, but somehow
some microbes are able to survive the consequences of the wide spectrum of
cytokines produced. One important mechanism of microbial killing is the
production of reactive nitrogen species activated by a variety of microbial
components through TLR pathways. TLR-mediated induction of calciumindependent nitric oxide synthase (iNOS) is necessary for killing of some
microbes. In human macrophages, TLR2 activates other potent microbicidal
mechanisms that are able to kill mycobacteria (Thoma-Uszynski et al., 2001).
Microbes

may

induce

iNOS

through

TLR2/TLR4/MyD88-independent

mechanisms, suggesting the involvement of receptors other than TLRs. Such
cross-talk between TLRs and other innate immune recognition receptors has
long been recognized in killing caused by production of reactive oxygen species,
where LPS primes activation of phagocyte oxidase induced by phorbol ester or
by phagocytic particles that do not utilize TLR pathways (Pabst and Johnston,
1980).

The process of phagocytosis also requires the recruitment of actin filaments for
the

internalization

process.

This

actin

recruitment

by

polymerization/

depolymerization exhibits the critical step during the phagocytic process.
Cytochalasin-D (Cyt-D), known to block actin polymerization by binding to the
barbed (plus) end of the actin filament, is described as a potent inhibitor of
phagocytosis (Wakatsuki et al., 2001; Tjelle et al., 2000). During internalization,
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activated macrophages generate ROS/RNS under activation of NADPH oxidase
(Park, 2003). This ROS generation may also act as a second messenger, which
can trigger several signalling pathways including the activation of NF-κB resulting
in the production of pro-inflammatory cytokines such as IL-6 and TNF-α (Iles and
Forman, 2002).

The discussion provided here demonstrates that phagocytosis is an inherently
complex process that requires coordinated activation of signaling leading to
events as diverse as actin remodeling, alterations in membrane trafficking,
particle engulfment, microbial killing, and production of appropriate inflammatory
mediators that direct the adaptive immune response. The consequences of
phagocytosis vary, and they depend on the identity of the microbial target and
the many factors that modulate the activation state of the phagocyte; for
instance, phagocytosis can induce superoxide formation and apoptosis in
macrophages (Park, 2003).

Many proteins have been identified that play important roles during phagocytosis,
and the application of high-throughput technologies is accelerating their
discovery. A central challenge in anti-inflammatory research will be to integrate
these molecules into pathways and networks that account for the diversity of
phagocytic

responses.

Pathogenic

microorganisms

have

sought

out

vulnerabilities in phagocytic mechanisms in their attempts to subvert defenses,
and the use of overlapping and redundant mechanisms during phagocytosis may
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reflect evolutionary pressures for the development of a complex, though highly
robust system. Studying of these networks and delineation of the phagocytosis
process is important in defining molecular targets and candidates that can
regulate macrophage phagocytic activity during inflammation.

1.3 Aryl hydrocarbon receptor (AHR) activation and oxidative stress
Increasing presence of environmental contaminants and poisonous polycyclic
aromatic hydrocarbons leads to high incidence rate of contact with these
toxicants and produces oxidative stress which raises a number of toxic and
carcinogenic responses in experimental animals and humans mediated for the
most part by the aryl hydrocarbon receptor (AHR) Barouki et al., 2007). The AHR
is a ligand-activated transcription factor whose central role in the induction of
drug-metabolizing enzymes has been well established and widely demonstrated.

It has been widely shown that the AHR molecule also functions in pathways
outside of its role in detoxification and that modulation of these pathways by
environmental AHR ligands may be an important part of the toxicity of these
compounds. The AHR molecule is a cytosolic ligand-activated transcription factor
that mediates many toxic and carcinogenic effects in animals and possibly in
humans (Pollenz, 2002). Activation of the AHR pathway in vertebrates causes
the toxic and carcinogenic effects of a wide variety of environmental
contaminants such as dioxin (TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin),
coplanar polychlorinated biphenyls (PCBs) and polycyclic or halogenated
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aromatic hydrocarbons (PAHs or HAHs). As a consequence of AHR activation,
many detoxification genes are transcriptionally induced, including those coding
for the Phase I xenobiotic-metabolizing cytochrome P450 enzymes of which
CYP1A1 is one the central players. Other molecules discovered to posess ability
to bind AHR include indirubin and indirubin-derivatives (Kawanishi et al., 2003).

Indirubin derivatives such as Indirubin-3’-(2,3 dihydroxypropyl)-oximether (E804)
have been demonstrated to block Stat3 signaling in human breast and prostate
cancer cells via interactions with AHR. Studies on AHR activation using indirubin
derivatives demonstrated that although derivatives such 6-Bromoindirubin-3’monoxime (BIO) and 5-Iodo-Indirubin-3’-monoxime (5-Iodo) bind to AHR and
induce its nuclear translocation, they also triggered ARNT-independent nuclear
redistribution of AHR (Knockaert et al., 2004). Indirubin-3-monoxime is an aryl
hydrocarbon receptor (AHR)-binding, idole-derived compound known to be a
potent inducer of CYP1A1, at least in hepatic cell lines and indirubin-3′monoxime has been demonstrated to either act as classical AHR ligand, or
modulates endogenous AHR-regulated activity in U937 histiocytic lymphoma
cells (Springs and Rice, 2006).

The persistence and prevalence of various exogenous AHR ligands in
environmental resources necessitates a search for molecules that can inhibit
AHR-mediated oxidative stress in an attempt to ameliorate AHR-induced disease
conditions.
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1.4 Didox as a candidate for regulation of oxidative sress
Didox(3,4-Dihydroxybenzohydroxamine) is a powerful synthetic antioxidant and
one of the most potent ribonucleotide reductase (RR) inhibitors, revealing an
antitumor effect in several experimental studies and has been shown to have the
capacity to downregulate NF-κB activation (Elford et al., 2007, Turchan et al.,
2003, and Inayat et al., 2002). Several lines of research have demonstrated that
Didox belongs to a unique class of more specific and more potent inhibitors of
RR enzyme activity than hydroxycarbamides. Furthermore, Didox has has been
shown to exhibit anti-tumour activity in several tumor models in both in vitro
studies and in vivo models (Elford et al, 1979; Mayhew et al., 1997, 2002;
Horvath et al., 2004a,b; Sumpter et al., 2004; Wakisaka et al., 2005).

Phase I trials, as well as phase II clinical studies, in patients with advanced
breast cancer showed minimal toxicity (Veale et al, 1988; Carmichael et al, 1990;
Rubens et al, 1991). It is therefore well established that Didox can be tolerated
by patients at high dosage without major side effect; this makes Didox safe for
use in clinical applications. Ribonucleotide reductase is a multisubunit enzyme
responsible for the reduction of ribonucleotides to their corresponding
deoxyribonucleotides, which are building blocks for DNA replication and repair in
all living cells. The key role of RR in DNA synthesis and cell growth control has
made it an important target for anticancer therapy. Increased RR activity has
been associated with malignant transformation, tumor cell growth and viral
replication. Based on the critical importance of RR in DNA synthesis and
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potential as a point of DNA synthesis regulation, efforts for new RR inhibitors
have been made in basic and translational research and Didox has been in the
forefront.

Didox has been demonstrated to inhibit oxidative stress and secretion of
inflammation mediators via suppression of NF-kB activity in various experimental
models. Didox ability to inhibit this preeminent inflammatory transcription factor,
NF-κB, is most probably due to its selective inhibition of phosphorylation of the
cytoplasmic inhibitor IκBα (Lee et al., 2007). In addition to comprising a new
class of antioxidants, Didox has been shown to be a potent chelator of iron, and
free radical scavengers (Ding et al., 1992, Elford et al., 1989). Whether these
interesting properties of Didox have other molecular effects that can be
potentially therapeutic in the treatment of chronic inflammatory dieases is
unknown. Didox, for example, protects against reperfusion injury in the rabbit
heart (Ding et al., 1992). These interesting properties have led us to investigate if
Didox has other molecular characteristics that are potentially therapeutic,
especially in disease conditions mediated by deregulated macrophage activation.

Many cancers arise from sites of infection, chronic irritation and inflammation,
making inflammatory cells (mainly macrophages) an important constituent of the
tumor microenvironment. The ability of Didox to suppress inflammation and the
important role of RR in DNA synthesis /repair makes it a worthy candidate and an
active area of interest for anticancer, antivirus and anti-inflammation research.
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Figure 1.4: A catalog of Didox properties that potentiates them as prolific
candidates for treatments of inflammatory diseases. Although it was primarily
synthesized as an inhibitor of ribonucleotide reductase, Didox has been shown to
possess a variety of anti-cancer and anti-inflammatory characteristics.

Among other characteristics (Fig 1.4) Didox also mediates radiosensitizing
effects in prostate cancer cells by abrogating the radiationinduced upregulation of
Bcl-2 expression and NF-κB activity. The properties of Didox that make it a
worthy anticancer candidate is well-demonstrated in its abilities to interfere with
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the “Hallmarks of cancer” which explain how cancers acquire their survival
capabilities. The introduction of adjacent hydroxyl groups increased inhibition of
RR, and the presence of the hydroxyl-groups in Didox compounds made it active
against L1210 leukemia. The presence of hydroxyl groups in the structure of
Didox has been attributed to most its promising therapeutic potential.

Didox has been demonstrated to significantly reduce oxidative stress that was
present in brain and cerebrospinal fluid (CSF) of HIV-infected patients. HIVinfected patients with dementia exhibit an accumulation of toxic substances in the
CSF that are capable of inducing oxidative stress. The anti-inflammatory effect
observed during treatment of HIV-infected patients using Didox presented it as
novel compound capable of blocking the CSF-induced toxicity, the therapeutic
potential of which is worthy of further exploration (Turchan et al., 2003). The
oxidative stress inhibitory potential of Didox and its ability to attenuate NF-κB
activity makes it a worthy candidate as a molecule that can modulate
macrophage activity and its role in inflammation.

As therapeutic choices for the treatment of inflammatory diseases that are
commonly chronic are coupled with severe side effects, the search for less
harmful and effective compounds continues to be a strong research area
(McKellar et al., 2007).
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CHAPTER 2:
DIDOX INHIBITS REACTIVE OXYGEN SPECIES PRODUCTION,
INFLAMMATORY EVENTS, PHAGOCYTOSIS ACTIVITY AND NFκB NUCLEAR TRANSLOCATION IN LPS-ACTIVATED RAW 264.7
MURINE MACROPHAGES.
ABSTRACT
Didox (3,4-Dihydroxybenzohydroxamic acid) is a synthetic antioxidant and one
of the most potent ribonucleotide reductase inhibitors, revealing an antitumor
effect in several experimental studies. In humans, tumorigenesis and many other
diseases which include

atherosclerosis, Parkinson's disease, heart failure,

myocardial infarction, Alzheimer's disease, and multiple sclerosis have been
strongly associated with elevated generation of inflammation and oxidative stress
by aberrant activation of macrophages. The role of Didox on oxidative stress
events produced in activated macrophages has not yet been fully investigated.
The first objective was to examine the cytotoxic and cytostatic effect of Didox on
Raw 264.7 cells so as to establish the optimal concentration to be used. The
MTT and colony formation assays showed that 100µM Didox was neither
cytotoxic nor cytostatic to these cells during the 24h period of treatment.

Analysis of more than 200 oxidative stress associated genes using mouse
oxidative stress, cytotoxicity and NF-κB RT2 ProfilerTM PCR-Arrays revealed that
100µM Didox treatment of Raw 264.7 macrophages significantly lowered LPSinduced expression of most inflammatory genes (iNOS, IL-1α, IL-1β, IL-6, TNF-α,
NF-κB, Cox-2, p38α, TLR4, GM-CSF, G-CSF, CCL2 and CCL4) while
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upregulating expression levels of most anti-inflammatory genes (Catalase,
glutathione peroxidase, IL-10, superoxide dismutase, and peroxiredoxins) in
these cells. Quantitative real-time PCR using selected primers confirmed that
Didox inhibited LPS-induced mRNA expression of iNOS, IL-6, IL-1, NF-κB (p65),
Cox-2, and TNF-α in Raw cells while upregulating antioxidant related gene
(glutathione peroxidase, catalse, and superoxide dismutase) expression after
24h of treatment.

Moreover, using the sandwich ELISA assay, it was demonstrated that Didox
dose-dependently inhibits LPS-induced IL-6 production in Raw 264.7 cells.
Western blot analysis showed that Didox suppressed LPS-induced protein
expression of Cox-2, iNOS, and TNF-α in Raw 264.7 macrophages. The Griess
reagent and DAF-2 DA assays showed that Didox inhibits LPS-induced secretion
and production of nitric oxide in Raw 264.7 cells. Didox also inhibited LPSinduced reactive oxygen species (ROS) production as assessed with the
dihydrodichlorofluorescein diacetate (CM-H2DCFDA) assay and evaluated using
Fluorescence Microscopy Analysis. Didox further blocked Buthionine Sulfoximine
(BSO) and LPS-induced ROS production in Raw 264.7 murine macrophages.
LPS-mediated oxidative burst and superoxide free radical productions in Raw
264.7 macrophages were also suppressed by addition of Didox as demonstrated
using the DHE assay.
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In additional functional assays, Didox inhibited both LPS-induced endocytosis of
FITC-labeled beads and phagocytosis of TRITC-labeled yeast cells in Raw 264.7
murine macrophages. Immuonofluorescence translocation studies with FITClabeled NF-κB (p65) and Western blot analysis showed that Didox inhibited LPSinduced p65 nuclear translocation in Raw 264.7 cells. These results suggest that
the pharmacological action of Didox observed in Raw 264.7 murine
macrophages is partly due to its potent anti-oxidative effects and antiinflammatory potential, and that these actions may be mediated via inhibition of
the NF-κB pathway. Didox may therefore play a major in managing disease
conditions exacerbated by of LPS-induced oxidative stress in macrophagemediated inflammation.

ABBREVIATIONS: Didox, 3,4-Dihydroxybenzohydroxamic acid; NO, Nitric oxide;
iNOS, inducible nitric-oxide synthase; LPS, lipopolysaccharide; NF-κB, nuclear
factor-κB, MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide;
H2DCFDA,

2’7’-dihydrodichlorofluorescein

diacetate;

BSO,

buthionine

sulfoximine; IL-6, interleukin 6; ROS, reactive oxygen species; FITC, fluorescein
isothiocyanate, MFI, mean fluorescence intensity; DHE, dihydroethidium; DAF-2
DA, 4,5-Diaminofluorescein Diacetate.
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INTRODUCTION
Reactive oxygen species (ROS) are a cluster of highly unstable compounds that
are generated during inflammation and normal cellular metabolism via
incomplete reduction of molecular oxygen. They consist of molecules with
unpaired electrons such as superoxide anions (O2− ) and hydroxyl radical ( OH),
and molecules that have oxidizing propensity but do not possess free electrons,
for example hydrogen peroxide (H2O2) and hypochlorous acid (HOCl) (Abid et al.,
2005) . These species are involved in the regulation of fundamental cellular
activities such as cell growth and differentiation (Dor and Porat, 2001; D'Angio
and Maniscalco, 2002, Hopf et al., 2005 , and Veal et al., 2007). However, their
overproduction and/or the presence of impaired antioxidant ability results in
oxidative stress which can induce and propagate significant injury. Likewise,
reactive nitrogen species (RNS), the by-products of nitric oxide (NO) metabolism,
play an important role in maintaining various physiological functions at basal
levels, and contribute to several pathological processes at high levels. Examples
of RNS include nitrite (NO2-), nitrate (NO3−) and peroxynitrite (ONOO−) and these
are produced in large amounts during the process of inflammation (Boueiz and
Hassoun, 2009).
Inflammation is a complex stereotypical response of the body to cell damage and
breaches in vascularized tissues. The inflammatory response is phylogenetically
and ontogenetically the oldest defense mechanism that is controlled by
cytokines, products of the plasma enzyme systems, lipid mediators released from
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different cells, and by vasoactive mediators released from mast cells, basophils
and platelets (Ross et al., 2002). However, deregulated inflammatory processes
induce overproduction of ROS/RNS and reduced cellular antioxidant capacity
leading to cellular oxidative stress. Cellular oxidative stress can be a
predisposing factor for cancer and inflammation-based disorders since it results
in oxidation of DNA, lipid bilayer fatty acids and proteins impairing their function
permanently. By oxidizing these vital molecules, oxidative stress can lead to DNA
mutation or damage, lipid peroxidation, protein degradation, and these factors
have been associated with inflammatory diseases such as

atherosclerosis,

multiple sclerosis, Parkinson's disease, heart failure, myocardial infarction,
Alzheimer's disease, chronic fatigue syndrome, and cancer (Khansari et al.,
2009).

A key player in inflammation is the macrophage whose wide tissue distribution
makes them well suited to provide an immediate defense against foreign
elements prior to leukocyte migration (Zhang et al., 2008). As macrophages
participate in both adaptive immunity and innate immunity against bacterial, viral
and fungal pathogens, they display a range of functional and morphological
phenotypes. The murine macrophage Raw 264.7 cell lines are the best model for
these studies since its lipopolysaccharide (LPS) -induced state exhibits these
typical functional and morphological phenotypes. LPS triggers the secretion of
nitric oxide (NO) and inflammatory cytokines through stimulating intracellular
signaling molecules such as Nuclear factor-κB (NF-κB) and mitogen-activated
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protein kinases (MAPKs) (Xie et al., 1994). Previous studies have suggested that
these LPS-induced pathways play a critical role in LPS-induced iNOS and IL-6
expression (Nam et al., 2007, Cho et al., 2003, Kim et al., 2006).

Nitric oxide, a small-molecule and membrane-permeable gas released by
activated macrophages, mediates many physiological events, and chronic
elevated nitric oxide is involved in the deamination of DNA and inactivation of
DNA repair enzymes, mechanisms that induce cancer (Kim et al., 2007, Kim et
al., 2004). Endothelial NO synthase (eNOS), neuronal NO synthase (nNOS), and
inducible NO synthase (iNOS) are the three key enzymes that generate nitric
oxide. iNOS is responsible for the overproduction of nitric oxide and is often
present during inflammation and carcinogenesis (Fukumura et at., 2006).
Expression of the iNOS gene in macrophages is regulated mainly at the
transcriptional level, particularly by NF-κB (Xie et al., 1994).

In unstimulated cells, NF-κB is constitutively localized in the cytosol as a
homodimer or heterodimer, and is associated with inhibitory IκB protein (IκB).
Activation of NF-κB is induced by phosphorylation of IκB, leading to its
degradation and to the translocation of NF-κB to the nucleus (Griscavage et al.,
1996). In this way, NF-κB regulates the inflammatory reaction by increasing the
expression of specific cellular genes (Yamamoto et al., 2001). Just like many
other NF-κB regulated genes there are NF-κB consensus DNA sequences within
the iNOS promoter (Yeo et al., 2003) that are responsible for LPS-induced NF-κB
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DNA binding activity. As a result, inhibition of signal transduction proteins in the
pathways leading to activation of NF-κB is now widely recognized as an
applicable strategy to combat inflammatory disease.

While therapeutic choices for the treatment of commonly occurring chronic
inflammatory diseases are coupled with severe side effects, the search for less
harmful and effective compounds continues to be a strong research area
(McKellar et al., 2007). Didox(3,4-Dihydroxybenzohydroxamine) is a simple,
synthetic antioxidant

and one of the most potent ribonucleotide reductase

inhibitors, revealing an antitumor effect in several experimental studies and has
been shown to have the capacity to downregulate NF-κB activation (Elford et al.,
2007, Truchan et al., 2003, and

Inayat et al., 2002). We have therefore

examined the effect of Didox on LPS-induced oxidative stress in Raw 264.7
murine macrophage cell line and show that it possesses potent anti-oxidative and
anti-inflammatory effects, and that these actions are mediated via inhibition of the
NF-κB pathway. These results suggest that Didox may therefore play a major
role in managing disease conditions associated with macrophage-mediated
inflammation.
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MATERIALS AND METHODS

Materials
Didox was provided by Dr. Howard Elford, Molecules for Health Inc. (Richmond,
VA) and phorbol-12-mristate-13-acetate (PMA) was purchased from A.G.
Scientific Inc., San Diego, CA. LPS from E. coli serotype R515(Re) (ultra pure,
TLR4grade™) was purchased from Alexis biochemicals, San Diego, CA and FBS
from Atlas Biological, Fort Collins, CO. Dulbecco's Modified Eagle Medium
(DMEM), fetal bovine serum (FBS), HEPES, glucose, sodium bicarbonate,
penicillin, streptomycin, paraformaldehyde, Triton X-100 , Sodium Borohydride,
buthionine sulfoximine and dimethyl sulfoxide (DMSO Hybri Max®) were
purchased from Sigma, St Louis, MO. H2DCFA, DHE, DAF-2 DA (Molecular
Probes, Eugene, OR) , rabbit anti-65 polyclonal antibody (Thermo Fisher Sci.,
Fremont, CA), goat-anti rabbit polocylonal Ab, Raw 264.7 murine macrophage
cells (ATCC®, Manassas, VA) , RT2 Profiler™ PCR Array System, RT2 First
Strand Kit and RT2 qPCR Master Mix were purchased from SABiosciences
Corp., Frederick, MD, PCR primers from IDT®, Coralville, IA, TRI-reagent® from
Molecular Research Center, Inc.Cincinnati, OH and Halt™ Protease Inhibitor
Cocktail from Thermo Fisher Sci., Rockford, IL. All other chemicals were
purchased from Sigma, St Louis, MO.
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Cell Cultures
Murine macrophage RAW 264.7 cells were cultured in Dulbecco’s modified
Eagle’s medium (DMEM) containing 25 mM HEPES buffer, 3 g/L D-glucose, 1.5
g/L sodium bicarbonate and 4 mM L-glutamine. The culture media were
supplemented with 10% fetal bovine serum, penicillin (100 units/ml) and
streptomycin (100 µg/ml). All cultures were maintained in a humidified incubator
in 5% CO2 at 37 °C and cells were be split for sub-culturing two times a week.

Treatment Preparations
Didox (3,4-Dihydroxybenzohydroxamine) was dissolved in dimethyl sulfoxide
(DMSO Hybri Max®

purchased from Sigma, St Louis, MO) to a final stock

concentration of 200 mM and further diluted in culture medium to the working
serially diluted concentrations ranging from 3.12 – 200 µM. LPS (E. coli,
Serotype R515 ultra-pure, TLR4 gradeTM purchased from Alexis Biochemicals,
San Diego, CA) was diluted in serum-free culture medium before adding to
culture treatments.

Determining cell cytotoxicity using MTT Assay
Cell

viability

was

determined

via

MTT

[3-(4,5-Dimethylthiazol-2-yl)-2,5-

diphenyltetrazolium bromide] assay which is based on the capacity of
mitochondrial succinyl dehydrogenase of viable cells to convert the soluble
yellow tetrazolium salt into an insoluble formazan product. Briefly 100 µl of cells
were seeded at 10

5

cells/well in 96-well plates and allowed to adhere for 3 h,
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thereafter Didox or LPS treatment was added to wells to give the desired final
concentrations as indicated under the figure legend. Controls without treatment
were run in parallel. Following a 24h or 48h incubation period with or without
treatment, 20 µl of a 5 mg/ml solution of MTT (Sigma, St Louis, MO) in
phosphate buffered solution (PBS) was added in the medium and the cells were
further incubated for 1 h at 37 °C. The culture medium was then completely
removed by aspiration and the dark blue crystal formazan resulting from the
reduction of MTT was dissolved by adding 200 µl of dimethyl sulfoxide (DMSO)
and the plates were left on a shaker for another 20 minutes. The optical density
(OD) was measured at 570 nm using a 96-well plate reader (µ-Quant, Bio-Tek
Instruments, Inc.) and cell proliferation was estimated as the percentage
absorbance of sample relative to control. All treatments and controls were
carried-out in triplicates and repeated three times to confirm reproducibility.

Cell staining for apoptotic nuclear morphology using Hoechst/PI double
stain.
RAW 264.7 cells were plated on glass cover-slips at a density of 1 × 106 cells/60mm dish and allowed to adhere for 3hr. Cells were then treated with media alone
or the combination of Didox (100 µM) and LPS (0.1 µg/ml) for a period of 24 hr
and then stained with Hoechst/PI regimen. Briefly, at 24 hr after treatment, the
cell media were removed by aspiration and the adhered cells were resuspended
in 500 µl of Hoechst 33342 dye (5 µg/ml). Cells were incubated for 15 min at
37°C followed by gentle addition of propidium iodide (10 µg/ml). The cells were
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then fixed as described above and mounted on glass slides for imaging using
epifluorescent microscope.

Gene Analysis using RT2 ProfilerTM PCR-Arrays.
Murine macrophage RAW 264.7 cells were seeded at 5 X 106 cells/ml in 75 cm2
culture flasks (Corning Inc., NY) and allowed to adhere to flask surfaces to 3h.
Cells were then treated with Didox (100 µM) and RNA was extracted from cells
after 24h using TRI-reagent® from Molecular Research Center, Inc.( Cincinnati,
OH) and retrotranscribed by RT-PCR first strant kit (SuperArray Bioscience
Corporation, Frederick, MD). To isolate RNA the cells were scraped from flask
surface using BD FalcomTM cell scraper (BD Biosciences, Bedford, MA) and
harvested by centrifugation. TRI-reagent® was added (1ml) to all cell pellets and
the mixture was homogenized by slow pippeting several times. The homogenate
was then incubated at room temperature for 5 min with addition of 0.2 ml
chloroform.

After incubating the mixture at room temperature for 15 min, the samples were
centrifuged at 12,000 x g, for 15 min at 4 °C. The aqueous phases were
transferred to a new 1.5 ml microcentrifuge tube. RNA from the aqueous phase
was precipitated by mixing with 0.5 ml isopropyl alcohol with incubation at room
temperatue for 10 min, and centrifuged at 12,000 x g for 15 min at 4 °C.
Precipitated RNA pellets were washed three times with 70% ethyl alcohol, and
redissolved in DEPC-treated water. After collecting 1µg RNA from each tube,
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Genomic DNA contamination was eliminated by using Genomic DNA elimination
mixture (SuperArray Bioscience Corporation, Frederick, MD) and cDNA
synthesis was carried using the RT cocktail (SuperArray Bioscience Corporation,
MD). Real-time PCR was then performed on BioRad iQ5 real-time PCR detection
system (Applied Biosystems) using Mouse Oxidative Stress RT2 Profiler PCR
Array and RT2 Real-Timer SyBR Green/qPCR Master Mix purchased from
SuperArray Bioscience Corporation (Frederick, MD). For data analysis the ∆∆Ct
method was used; for each gene fold-changes were calculated as difference in
gene expression between untreated controls and treated cell cultures. A positive
value indicates gene up-regulation and a negative values indicate gene downregulation.

RT-PCR validation assays
To validate the results obtained from the PCR Array, RNA was extracted and
cDNA obtained from treated murine macrophages as mentioned above. mRNA
levels were analysed by by real-time PCR using the following conditions: 1 cycle
at 95°C for 10 min, 40 cycles at 95°C for 15 sec, 55°C for 1 min and quantified
using selected primers (Table 2.1). The quantity of these mRNAs was expressed
as fold-changes compared to the untreated Raw 264.7 murine macrophage
controls using β-actin controls.
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Table 2.1: Primer sequences used for of Real Time-PCR evaluation of
inflammation associated genes in LPS-activated Raw 264.7 cells after treatment
with Didox.

Gene
iNOS

COX-2

IL-6

p65

GPx

SOD1

CAT

TNF-α

β-actin

Sequence
F: 5'-AATGGCAACATCAGGTCGGCCATCACT-3'
R: 5'-GCTGTGTGTCACAGAAGTCTCGAACTC-3'
F: 5'-GGAGAGACTATCAAGATAGT-3'
R: 5'-ATGGTCAGTAGACTTTTACA-3'
F: 5'-GAGGATACCACTCCCAACAGACC-3'
R: 5'-AAGTGCATCATCGTTGTTCATACA-3'
F: 5‘ -TCATCTTCCCGGCAGAGCCAG-3’
R: 5’-GTGGGTCTTGGTATCTGT-3’
F: 5'-GGTTCGAGCCCAACTTTACA-3'
R: 5'-CGGGGACCAAATGATGTA CT-3'
F: 5'-CGGATGAAGA GAGGCATGTT-3'
R: 5'-CACCTTTGCCCAAGT CATCT-3'
F: 5'-TTGACAGAGAGCGGA TTCCT-3'
R: 5'-AGCTGAGCCTGACTCTCCAG 3'
F: 5'-GCCAGAGGGCTGATTAGAGA-3'
R: 5'-TCTTCTGCCTGCTGCACTT-3'
F: 5'-TCATGAAGTGTGACGTTGACATCCGT-3'
R: 5'-CCTAGAAGCATTTGCGGTGCACGATG-3'
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Measurement of NO production using nitrite assay
For evaluating the possible effect of Didox on LPS-induced NO production, Raw
264.7 cells in MEM (without phenol red) media were plated at a density of 105
cells/well in 96-well culture plate and grown for 3 h to allow them to attach to the
plate. Didox was added to the wells at desired final concentrations in the
absence or presence of LPS (0.1µg/ml). The cells were further incubated for 24
h.

Control cells were grown under identical conditions except without tested

compounds. After that, the supernatants were collected for determination of
nitrite as an index for nitric oxide (NO) production. NO synthesis in cell culture
was measured using Griess reagent. Briefly, 100µl/well of sample was incubated
with equal volume of Griess solution (0.1% naphthylethylenediamine and 1%
sulfanilamide in 5% H3PO4 solution) at room temperature for 10 min. The
absorbance was measured with a 96-well plate reader (µ-Quant, Bio-Tek
Instruments, Inc.) at 550 nm. Nitrite concentration was determined by using
sodium nitrite as a standard. The level of nitrite, a more stable NO metabolite,
reflects NO synthesis since NO has a very short half-life.

Determination of IL-6 production by murine macrophage Raw 264.7 cells
After treatment of cells in the 96-well plates and incubation at appropriate time
intervals, cell culture supernatants were removed for cytokine determination
assays. The cell culture supernatants were collected and analyzed for IL-6
proteins using commercial ELISA kits Mouse IL-6 ELISA Ready-SET-Go!
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(eBioscience, San Diego, CA). The protocols provided by the manufacturers
were followed to the detail. Briefly, NUNC Maxisorp 96 well ELISA plates were
coated with 100µl/well of capture antibody overnight and after five washes,
100µl/well of detection antibody is added followed by 1h incubation at room
temperature. After proper washing, avidin-HRP (horse radish peroxidase) was
added at 100µl/well and incubated plate at room temperature for 30 minutes. The
avidin-HRP was replaced with substrate solution for 15 minutes and after
addition of a stop solution the optical density (OD) can be measured at 450 nm
using an ELISA plate reader (µ-Quant, Bio-Tek Instruments, Inc.). IL-6 protein
concentration was quantified from a standard curve constructed from serially
diluted standard concentration readings in appropriate wells. All treatments and
controls were carried in duplicates and repeated three times to confirm
reproducibility.

Evaluation of ROS production using fluorescent microscopy
Cells were seeded at 5 x 105 cells/well in eight chamber cell culture slides for 3h
and then treated with Didox (100µM), BSO (400µM) in the presence or absence
of LPS (1µg/ml). After 24h incubation, H2DCFA solution was added at 10 µM to
all wells and incubated for an additional 30 min at 37˚C. The slides were washed
twice with PBS, fixed with chilled absolute methanol for 1 min and mounted using
glycerol:PBS (1:1) solution. The cover slips were placed over the mounting
medium and the slides sealed using nail polish. The slides were then viewed
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under the fluorescence microscope and images capture using the digital camera
with quantification done using the Nikon NIS elements software.
Assessment of intracellular superoxide radical production in Raw 264.7
cells.
Superoxide production in Raw cells was assayed by using the oxidative
fluorescent dye DHE. DHE is oxidized on reaction with superoxide to ethidium
bromide, which mostly binds to DNA in the nucleus and fluoresces red. Cells
were seeded on cover slips at 2 x105 cells/well (in 6-well plates) for 3hrs. To
quench out any residual fluorescence, cells were treated with 0.01% sodium
borohydride (in PBS) for 5 min. After loading cells with 10 µM DHE for 15min,
cells were treated for 24h with 100 µM Didox in the presence or absence of LPS
(0.1µg/ml). Cells were fixed and mounted on slides and analyzed using the Nikon
AZ100 Epi-Fluorescent Microscope. The un-oxidized DHE remains blue (λEx\Em
=355\420nm) while the oxidized DHE fluoresces red (λEx\Em=355\420nm). Images
were captured using the NIS-Elements Viewer 3.0.

Intracellular NO production and iNOS activity in Didox-treated Raw 264.7
murine macrophages.
4,5-Diaminofluorescein Diacetate (DAF-2 DA), can be used for real-time
bioimaging of NO with fine temporal and spatial resolution. A membranepermeable DAF-2 DA is hydrolyzed by cytosolic esterases releasing free DAF-2
DA that does not leak into the medium. At physiological pH, the DAF-2 is
relatively non-fluorescent, however, in the presence of NO and oxygen, DAF-2
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triazole (DAF-2T), a fluorescent product, is formed. Cells were seeded on cover
slips at 2 x105 cells/well (in 6-well plates) for 3hrs. To quench out any residual
fluorescence, cells were treated with 0.01% sodium borohydride (in PBS) for 5
min. After loading cells with 10 µM DAF-2 DA for 15min, cells were treated for
24h with 100 µM Didox with or without LPS (0.1 µg/ml). Cells were fixed and
mounted on slides and analyzed using the Nikon AZ100 Epi-Fluorescent
Microscope.

Western Blot Analysis
Murine macrophage RAW 264.7 cells were seeded in 6-well plates to final
volume of 5ml

at 2.5 x 106 cells/ml and incubated at 37ºC for 3 h before

treatment with Didox or LPS. After treatment the culture medium was replaced
with 500 µl of Lysis Buffer (50 mM Tris base, pH 8, 150 mM NaCl, 1% IGEPAL
CA 630, 0.1 % SDS, Protease Inhibitor cocktail) and cells lysed on ice for 30 min
with constant shaking. The lysates were then transferred to 1.5 ml microfuge
tubes and the insoluble membrane fraction separated from the soluble fraction by
centrifuging at 10,000 x g for 10 minutes. The soluble fraction was mixed with
sample buffer and boiled for 10 minutes.

Electrophoresis was performed using 4-20% TBE CititerionTM Precast Gels (BioRad Lab, Inc. Hercules, CA) for 1 hr (200 V, 1 µg protein per lane) in electrode
buffer (25 mM Tris base, 190mM Glycine, 0.1% SDS). Separated proteins were
transferred to nitrocellulose membranes for 1hr (<100kDa) or overnight
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(>100kDa) at 100V or 30V respectively in transfer buffer (25 mM Tris, 190 mM
Glycine, pH 8.1-8.4) followed by incubation in 0.01M PBS containing 0.1%
Tween 20, 3% BSA, and 0.1% gelatin to block nonspecific IgG binding, followed
by treatment with specific primary antibodies for 30-45 min. The membranes are
then incubated with alkaline phosphatase-conjugated secondary antibody for 3045 min. The Western blot analysis was developed using substrate buffer [0.1 M
Tris buffer, 0.1M NaCl, 5 mM MgCl2 pH 9.5, mixed with 1% NBT:BCIP (2:1)].

Preparation of cytosolic and nuclear extracts
For cytosolic protein extraction, Raw 264.7 macrophages were resuspended in
500 µL of buffer A (10 mM HEPES, 10 mM KCl, 1 mM MgCl2, 5% glycerol, 0.5
mM EDTA, 0.1 mM EGTA, 1X protease inhibitor solution, 2 mM PMSF and 0.5
mM DTT) and incubated on ice in slow shaker for 15 min followed by addition of
0.65% of NP-40 . The mixture was vigorously vortexed for 10s and centrifuged at
12,000 x g for 1 min. For nuclear protein extraction, the resulting nuclear pellets
were resuspended in 500 µL of high salt buffer B (20 mM HEPES, 1% NP-40,
400 mM NaCl, 10 mM KCl, 1 mM MgCl2, 20% glycerol, 0.5 mM EDTA, 0.1 mM
EGTA, 1X protease inhibitor solution, 2 mM PMSF and 0.5 mM DTT) and
incubated on ice in slow shaker for 1 hr. The mixture was vigorously vortexed for
15s followed by centrifugation at 12,000 x g for 5 min.
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NF-κ
κB translocation immunofluorescence assay
Raw 264.7 murine cells were cultured in 8-chamber slides at 2 x105 cells/well
and seeded for 3hrs before treatment with Didox, LPS or combination of both for
90 min. After fixation with 4% PFA cells were permeablized with 0.1% Triton X100, 1%BSA for 30 min. Any possible background fluorescence was quenched
by incubating cells in 0.01% sodium borohydride (in PBS) for 5 min and nonspecific binding sites were blocked by adding 1% BSA with 1 hr incubation. Cells
were incubated for 60 min with rabbit anti-p65 antibody (1:1000) (purchased from
Thermo Fisher Sci., Fremont, CA) followed by FITC-labeled goat anti-rabbit
secondary Ab incubation for 60 min. After 5 min nuclear staining with DAPI cells
were mounted on slides using 50% glycerol and analyzed using the Nikon AZ100
Epi-Fluorescent Microscope. Images were captured using the NIS-Elements
Viewer 3.0.

WEHI Bioassay for TNF-α production
The production of TNF-α by Raw 264.7 macrophages can be evaluated further
using a bioassay which measures the cytotoxicity of this cytokine on TNF-α
sensitive WEHI-164 cells. The WEHI 164 fibrosarcoma cell line assay described
below can be used for assaying TNF-α by measuring cell survival after treatment
with supernatants obtained from Raw 264.7 cells. TNF-α induces cell death via
apoptosis in WEHI-164 cells and this assay was used to analyze the production
and secretion of bioactive TNF-α. Raw 264.7 murine macrophages were treated
with Didox, LPS or their combination for 24h and the supernatants were
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collected. WEHI-164 cells were cultured cells in 96 well plates at 5 x 104
cells/well and incubated for 2-3h in 37◦C humidified incubator to allow adherence
to the plate surface. Several 1:5 dilutions of supernatants collected from Raw
cells conditioned media were added in triplicate wells containing seeded WEHI
cells and further incubated for 24h in 37◦C humidified incubator with 5% CO2.
Afterwards the media was aspirated and replaced with MTT working solution (5
mg/ml) and incubated for incubate for 4h at 37◦C until the blue formazan was
visible. The MTT was then aspirated and DMSO was added to solubilize the
formazan on shaker for 10 min. The absorbance was read at 570nm and the
percentage of surviving cells was calculated in comparison with control cells.
Control cells were established by treating WEHI cells with supernatants obtained
from untreated Raw 264.7 cells. The assay was repeated three times and a
representative image of cells was photographed using the Nikon AZ100
Microscope.

Bioassay for IL-6 production using B9 cell lines
The production of IL-6 by Raw 264.7 macrophages was evaluated using a
bioassay which measures the proliferative effect of this cytokine on IL-6
dependent B9 cell lines. The IL-6 dependent murine hybridoma cell line B9
provides a reliable and sensitive assay for measuring IL-6 production in
mammalian

cultures.

B9

cells

were

cultured

in

RPMI-1640

medium

supplemented with 10% FBS and IL-6. For the bioassay, B9 cells were washed
and seeded to a density of 2.5 x 104 cells/well in 96-well microtiter plates. A 1:5
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dilution of supernatants obtained from Didox (100 µM) and LPS (0.1 µg/ml)
treated Raw cells was added in triplicates and incubated for 24h in a 37◦C
humidified incubator with 5% CO2. B9 cells treated with cultured media alone
were used as negative controls. Afterwards the plates were centrifuged at 500 x
g for 10 min to pellet cells and media was aspirated to be replaced with MTT
working solution (5 mg/ml) and incubated for incubate for 4h at 37◦C until the blue
formazan was visible. The MTT was then aspirated and DMSO was added to
solubilize the formazan on shaker for 10 min. The absorbance was read at
570nm and the stimulation index was calculated in comparison with control cells.
Control cells were established by treating B9 cells with supernatants obtained
from untreated Raw 264.7 cells. The assay was repeated three times and a
representative image of cells was photographed using the Nikon AZ100
Microscope.

Phagocytosis Assay (Microscopic analysis using FITC-beads)
For determination of effect of Didox of macrophage functionality, Raw 264.7
murine macrophages were seeded at 105 cells/well in 8-chamber glass slides
and incubate for 3hrs followed by treatment with LPS (0.1µg/ml), CytA (1 µM)
and Didox (100µM) for 30 min. FITC-labelled beads were added at 0.1 mg/ml or
106 particles per well and incubated for 30 min in 37◦C incubator. After washing
with PBS, 100 µl Trypan blue (2 mg/ml in 20 mM citrate, 150 mM NaCl, pH 4.5)
was added to quench extracellular FITC beads for 2 minutes. Cells were fixed by
incubating in 4% PFA for 30 min and mounted onto coverslip using 50 % glycerol
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(in PBS). Sealing was done using colorless clear nail polish and cells were
evaluated using the Nikon AZ100 Epi-Fluorescent Microscope and images
captured using the NIS-Elements Viewer 3.0. The percentage of phagocytosis of
FITC-labeled beads was quantified microscopically by counting at least 100 cells
in randomly selected fields per well, and an average between the duplicate wells
was calculated. Phagocytic index was calculated as: (average number of beads
phagocytosed per macrophage) x (% macrophages that had phagocytosed one
or more beads).

Statistical Analysis
All experiments are representative of three repeats carried out in triplicates and
the error bars represent the standard deviation from the mean average. All data
representations were analyzed using Graphpad PRISM 4.0 (Graphpad, San
Diego, CA, USA) or Sigmaplot (SPSS). p<0.05 would be considered to be
statistically significant.

RESULTS

Determination of effect of Didox on Raw 264.7 cell viability.
The effect of Didox on Raw 264.7 cell viability was determined by the
mitochondrial-dependent reduction of yellow MTT [3-(4,5-dimethylthiazol-2-yl)2,5-diphenyltetrazoliumbromide]

to

blue

formazan.

Raw

264.7

murine

macrophages were seeded at 105 cells/well in 96-well plates for 3h and then
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treated with increasing concentrations of Didox (0-200µM) in the presence or
absence of LPS for 24h. Replacing the media with MTT solution revealed that
cell viability was maintained above 90% at the concentrations tested with no
significant indication of cytotoxicity (Fig 2.1) and the PI exclusion assay showed
that cells exhibited no signs of apoptosis (Fig 2.2). To further evaluate cell
integrity and long-term effect of Didox on Raw 264.7 murine macrophages,
microscopic images of cells were captured at 12h intervals for up to 72h with no
significant change in cell turnover or morphology (Fig 2.3).
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Figure 2.1. Effect of Didox on cell viability of LPS-stimulated Raw 264.7 murine
macrophages. Raw 264.7 murine macrophages were incubated with Didox (0-200µM)
and LPS (0.1µg/ml) for 24h and cell viability was quantified using the MTT assay. Each
value represents the mean ± SD of three experiments performed in triplicates.
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50 µm

Figure 2.2. Didox-treated Raw 264.7 macrophages exclude PI dye and exhibit no signs of
apoptosis during 24h period.

Raw 264.7 murine macrophages were seeded on

coverslips and incubated with Didox (100µM) and LPS (0.1µg/ml) for 24h followed by
incubation with PI/Hoechst 33342 stain. Each value represents the mean ± SD of three
experiments performed in triplicates. After mounting, slides were view under fluorescent
microscope and images captured using Nikon NIS Elements viewer.
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100 µm

Figure 2.3. Didox exhibits no cytostatic effect on Raw 264.6 cells for up to 48h of
treatment. Raw 264.7 macrophages were seeded at 5 x 104 cells/well on coverslips in 6well plates and incubated with Didox (100µM) and LPS (0.1µg/ml) for up to 48hr and
growth was monitored every 12h using microscope DIC filter and images captured using
Nikon NIS Elements viewer.
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Analysis of oxidative stress associated genes using mouse oxidative
stress, cytotoxicity and NF-κB RT2 ProfilerTM PCR-Arrays.
Quantification of oxidative stress-associated genes is an important element in
studies of inflammation and immune responses. Quantitative RT-PCR, a rapid
and sensitive assay, is the preferred method to quantify gene mRNA levels
because they are often expressed at low levels. The PCR Array System offers a
simple, reliable and sensitive tool for multiple gene profiling. Using the Mouse
Oxidative stress and NF-κB PCR Array, the mRNA levels of 84 different oxidative
stress-related genes in LPS-stimulated and untreated Raw 246.7 murine
macrophage cells versus their Didox-treated (100µM) counterparts were
monitored. The gene expression results identified a number of up-regulated and
down regulated genes upon 24 h of treatment. At 24 hours, the positive effects of
LPS on pro-oxidant genes such as CSF’s, Chemokines, TLR’s, IL1a, IL1β, IL6,
iNOS, NF-κB(p105) and TNF were observed, while its inhibitory effect on antioxidant related genes such as IL-10 and Gpx2 was evident twenty-four hours
after stimulation (Table 2.2). Didox treatment lowered expression levels of most
inflammatory genes while upregulating expression levels of most antiinflammatory genes.
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Table 2.2 A-D. Downregulation of oxidative stress associated mRNA gene levels by
Didox in LPS-stimulated raw 264.7 murine macrophages. The Mouse Oxidative stress
and NF-κB PCR Array was used to evaluate the mRNA levels of 84 different oxidative stressrelated genes in Raw 246.7 murine macrophage cells treated with LPS(0.1µg/ml), Didox
(100µM), or both. PCR was performed on BioRad iQ5 real-time PCR detection system as
indicated in the methods. For data analysis the ∆∆Ct method provided by SABioscience was
used; for each gene fold-changes were calculated as difference in gene expression between
untreated controls and treated cell cultures. A positive value indicates gene up-regulation
and a negative value indicates gene down-regulation.

A. Oxidative stress associated genes
GenBank Acc. No.

Gene Name

DX

LPS

LPS+DX

NM_011611

Cd40

-2.81

7.37

3.76

NM_011333

Ccl2

-4.12

23.40

-1.54

NM_011337

Ccl3

-1.57

6.93

1.65

NM_009969

Csf2

-3.42

6.30

1.81

NM_009971

Csf3

-13.47

92.33

3.14

NM_009652

Akt1

-8.35

4.14

-2.91

NM_010336

Edg2

2.17

3.02

6.30

NM_021274

Cxcl10

-5.98

3.23

-4.86

NM_030677

Gpx2

2.25

-3.09

5.23

B. NF-κB transcription factor associated genes
GenBank Acc. No.

Gene Name

DX

LPS

LPS+DX

NM_008689

NFκB1

-2.70

1.09

-1.62

NM_019408

NFκB2

-2.77

1.45

1.00

NM_009045

RELA

-1.91

1.13

-4.12

NM_033601

BCL3

14.73

4.06

18.09
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C. Inflammation-associated cytokines
GenBank Acc. No.

Gene Name

DX

LPS

LPS+DX

NM_010548

IL10

1.34

-1.50

1.35

NM_010554

IL1α

-4.45

7.23

5.49

NM_008361

IL1β

-7.35

6.75

5.59

NM_008362

IL1R1

-1.74

10.35

2.70

NM_031168

IL6

-9.26

26.49

7.21

NM_013693

Tnf

-4.33

1.47

-3.63

NM_009425

Tnfsf10

-1.81

7.72

1.24

D. Toll-like Receptor associated genes
GenBank Acc. No.

Gene Name

DX

LPS

LPS+DX

NM_126166

TLR3

-1.11

4.98

3.40

NM_021297

TLR4

-2.84

2.75

-2.07

NM_008363

IRAK1

-1.61

9.71

-2.11

NM_172161

IRAK2

-1.88

3.08

-1.63

NM_011945

MAP3K1

-1.36

2.71

-1.78

NM_011952

MAPK3

1.10

5.15

1.12

NM_010851

Myd88

-1.63

1.59

1.05
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Validation of RT-PCR array results of selected genes using specific
primers.
To validate the results obtained using the RT2 ProfilerTM PCR-Arrays, an
additional RT-PCR analysis was carried out using selected primers to evaluate
the expression levels of genes involved in inflammatory pathways. These RTPCR assays showed that LPS-treatment increases mRNA expression levels of
NF-κB (p65), TNF-α, iNOS, IL-6, and Cox-2 genes (Fig 2.4A-E). On the other
hand, addition of Didox reduced expression of these LPS-induced mRNA
expression levels after 24h of treatment. Didox treatment of Raw 264.7 murine
macrophages led to upregulated mRNA expression levels of antioxidant-related
genes such as Gpx, Cat, SOD(Fig 2.4F-H).
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Figure 2.4: Real-time PCR data showing modulation of antioxidant and oxidative
stress associated mRNA gene levels in LPS-stimulated Raw 264.7 murine
macrophages by Didox. RT-PCR was conducted using cDNA from LPS-stimulated Raw
264.7 murine macrophages treated with Didox (100 µM) for 24h. Primers used are outlined
in Table 1. LPS-treatment increases mRNA expression levels of iNOS (A), IL-6 (B), TNF-α
(C), Cox-2 (D), and NF-kB(E) with variable inhibition by Didox. Didox treatment upregulated
mRNA expression of Gpx1 (F), SOD1 (G), and Cat (H). Each value represents the mean ±
SD of three experiments performed in triplicates using β-actin as the PCR control.
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Didox

inhibits

LPS-induced

NO

secretion

in

Raw

264.7

murine

macrophages.
Activated macrophages produce NO in large amounts during LPS-stimulation
and inflammatory responses. Since NO production is mediated by iNOS and RTPCR results indicated an inhibitory role of Didox on iNOS mRNA expression, it
was important to evaluate the effect of Didox on NO production in these LPSactivated macrophages. To assess the effect of Didox on LPS-induced NO
production in RAW 264.7 macrophages, cell culture medium was harvested after
treatment, and the concentration of accumulated nitrite, the oxidative product of
NO, was determined by the Griess method. Didox significantly (p<0.01) inhibited
LPS-induced NO release in RAW 264.7 cells in a concentration-dependent
manner (Fig 2.5). Didox at 100µM significantly decreased NO production while
maintaining cell viability of Raw 264.7 macrophages around 100% and although
200µM Didox decreased NO production further, cell viability was also slightly
lowered.
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Figure 2.5. Didox inhibition of NO production in LPS-induced Raw 264.7 murine
macrophages. Raw 264.7 murine macrophages were incubated with or without Didox
(6.25-200µM) and LPS (0.1µg/ml) for 24h and NO production quantified using the Griess
reaction with sodium nitrite standard. Each value represents the mean ± SD of three
experiments performed in triplicates. (*) indicates p<0.05 vs. the LPS-treated control group
not treated with Didox.

Didox suppresses intracellular NO production and iNOS activity in LPSinduced Raw 264.7 murine macrophages.
For direct measurement of intracellular production of NO in cells, 4,5Diaminofluorescein Diacetate (DAF-2 DA), can be used for real-time bioimaging
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of NO with fine temporal and spatial resolution. Cells were treated with Didox or
LPS and then loaded with the membrane-permeable DAF-2 DA which is
subsequently hydrolyzed by cytosolic esterases releasing free DAF-2 DA that
does not leak into the medium. At physiological pH, the DAF-2 is relatively nonfluorescent, however, in the presence of NO and oxygen, DAF-2 triazole (DAF2T), a fluorescent product, is formed. The fluorescent images showed that
treatment of cells with LPS produced more DAF-2 fluorescence compared to
control and Didox addition inhibited LPS-induced fluorescence or NO production
in Raw 264.7 cells (Fig 2.6 & Fig 2.6b).

Dose-dependent reduction of LPS-induced IL-6 production in Raw 264.7
murine macrophages by Didox.
Interleukin-6 is one of the major inflammatory cytokines produced and secreted
by LPS-activated macrophages. A sandwich ELISA assay was employed to
measure the effect of Didox on IL-6 secretion in Raw 264.7 murine macrophage
cells since Didox inhibitory effect was observed on IL-6 mRNA expression using
RT-PCR. Cells were incubated with LPS (0.1 µg/ml) or Didox (0, 6.25, 12.5, 25,
50, 100, and 200 µM) and culture medium harvested after 24h and analysed for
IL-6 production using Mouse IL-6 ELISA Ready-SET-Go! Kit. Didox significantly
decreased IL-6 production in a dose-dependent fashion (p<0.01) as compared to
the LPS-stimulated cells. Didox at 100 µM reduced IL-6 production ten-fold after
24 h (Fig 2.7). The B9 bioassay for IL-6 production also confirmed that Didox
inhibits IL-6 production in LPS-stimulated Raw cells. When supernatants from the
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20 µm

Figure 2.6. Assessment of intracellular NO production using DAF-2 DA
detection system in Raw 264.6 cells treated with LPS in the presence or
absence of Didox. Cells were seeded on cover slips at 2 x105 cell/well (in 6-well
plates) for 3hrs. After loading cells with 10 µM DAF-2 DA for 15min, cells were
treated with Didox (100µM) or LPS (1µg/ml). DAF-2T product fluoresces green
upon reaction with NO. Cells were fixed and mounted on slides and analyzed using
the Nikon AZ100 Epi-Fluorescent Microscope.
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Figure 2.6b. Quantitative assessment of intracellular NO production using DAF-2
DA detection system in Raw 264.6 cells treated with LPS in the presence or
absence of Didox. Cells were seeded on cover slips at 2 x105 cell/well (in 6-well plates)
for 3hrs. After loading cells with 10 µM DAF-2 DA for 15min, cells were treated with
Didox (100µM) or LPS (1µg/ml). DAF-2T product fluoresces green upon reaction with
NO. Cells were imaged using Nikon AZ100 Epi-Fluorescent Microscope under 488nm
fluorescence wavelength, DIC-high, and the two were overlayed using the NIS-Elements
Viewer 3.0. Mean fluorescence intensities were measured in various fields in triplicates
and treatment effects were analysed using the paired t-test and p<0.05 (*) was
considered to be statistically significant compared to controls (unless otherwise
indicated)
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Figure 2.7. Didox inhibits IL-6 production in LPS-stimulated Raw 264.7 murine
macrophages. Raw 264.7 murine macrophages were incubated with Didox (0-200µM)
and LPS (0.1µg/ml) for 24h and IL-6 production was measured from collected
supernatants using the ELISA Ready-SET-Go Kit. Each value represents the mean ±
SD of three experiments performed in triplicates. (*) indicates p<0.05 vs. the LPStreated control group not treated with Didox.
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100 µm

Figure 2.7b. Bioassay for IL-6 using the B9 cell line confirms that Didox inhibits
IL-6 production in LPS-stimulated Raw 264.7 murine macrophages. Raw 264.7
murine macrophages were incubated with Didox (100µM) and LPS (0.1µg/ml) for 24h
and collected supernatants diluted 1:5 were used to treat WEHI cells for 24h . Cell
viability was detected using the MTT assay and the stimulation index was determined
by dividing OD570nm (sample) with OD570nm (Control). After pelleting cells in the 96-well
plate a representative image of cells was photographed using the Nikon AZ100

Microscope
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Didox and LPS treated Raw cells were used for treatment of WEHI cells,
supernatants from DX treated cells resulted in minimal B9 growth compared to
LPS counterparts. Supernatants from Raw cells treated with combination of DX
and LPS resulted in lower B9 growth stimulation than those from LPS-treated
cells(Fig 2.7b).

Didox inhibits H2O2 production in Raw 264.7 murine macrophages treated
with BSO, PMA, LPS or their combinations.
During inflammatory reactions, activated macrophages produce H2O2 in large
amounts. Catalase is a major antioxidant enzyme catalyzing the decomposition
of hydrogen peroxide (H2O2 ) and its mRNA levels were upregulated by Didox as
shown using RT-PCR. H2O2 production in Raw 264.7 cells was therefore
determined using H2DCFA (2’,7’-dichlorodihydrofluorescein diacetate) assay after
treatment with Didox (100µM), buthionine sulfoxamine, BSO (400µM) in the
presence or absence of LPS (0.1µg/ml). H2DCFA is a cell-permeant fluorogenic
indicator for reactive oxygen species (mainly H2O2) that is non-fluorescent until
the acetate groups are removed by intracellular esterases and oxidation occurs
within the cell in the presence of H2O2. Higher intracellular fluorescence was
observed in BSO and LPS or PMA-treated cells compared to untreated controls.
Didox (100 µM) inhibited H2O2 production in both BSO and LPS or PMA-treated
cells as indicated by low intracellular DCFA fluorescence compared to BSO and
LPS-treated cells (Fig 2.8A and 2.8B). Mean fluorescence intensities were
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quantified using the Nikon NIS-Elements Viewer software and confirmed higher
mean fluorescence intensities in BSO and LPS or PMA-treated cells compared to
Didox-treated cells (Fig 2.8C).

A

B
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C

Figure 2.8. Didox inhibits ROS generation in BSO and LPS-stimulated Raw 264.7
murine macrophages. Cells were seeded at 5 x 10

5

cells/well in eight chamber cell

culture slides for 3h and then treated with Didox (100µM), in the presence or absence of
LPS (1µg/ml) [A], BSO (400µM) [B] or combination. After 24h incubation, H2DCFA
solution was added to all wells and incubated for an additional 30 min at 37˚C. Cells
were imaged using Nikon AZ100 Epi-Fluorescent Microscope under 488nm fluorescence
wavelength, DIC-high, and the two were overlayed using the NIS-Elements Viewer 3.0.
Mean fluorescence intensities were measured [C] in various fields in triplicates and
treatment effects were analysed using the paired t-test and p<0.05 (*) was considered to
be statistically significant compared to controls (unless otherwise indicated)
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Didox inhibits production of superoxide radicals by LPS- and PMAactivated RAW 264.7 macrophages
Since RT-PCR analysis showed an up-regulation of SOD in Raw 264.7 cells
treated with Didox it was important to assess the intracellular levels of
superoxides in these cells after treatment with Didox. To achieve this, cells were
treated with Didox in presence or absence of LPS for 24h and then loaded with
DHE for 2h in presence or absence of PMA. DHE-positive cells fluoresce red
while unoxidized DHE remains blue. DHE-positive cells were assessed using a
fluorescent microscope and superoxide production was quantified by measuring
fluorescence intensity. Treatment of Raw 264.7 cells with LPS and PMA resulted
in robust intracellular O2● production whereas addition of Didox significantly
decreased O2● production (Figure 2.9, 2.10 and 2.10b).
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20 µm

Figure 2.9. Didox inhibits production of superoxide radicals by LPS-activated
RAW 264.7 macrophages. Cells were treated with Didox in presence or absence of
LPS for 24h on glass coverslips and then loaded with DHE for 2h. DHE-positive cells
fluoresce red and localize mostly in the nucleus while unoxidized DHE remains blue.
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Figure 2.10. Didox inhibits production of superoxide radicals by PMA-activated
RAW 264.7 macrophages. Cells were treated with Didox or PMA in presence or
absence of BSO for 24h on glass coverslips and then loaded with DHE for 2h. DHEpositive cells fluoresce red and localize mostly in the nucleus while unoxidized DHE
remains blue.
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Figure 2.10b. Quantitave analysis of production of superoxide radicals by LPSactivated RAW 264.7 macrophages after treatment with Didox. Cells were treated
with Didox, LPS or PMA in presence or absence of BSO for 24h on glass coverslips and
then loaded with DHE for 2h. DHE-positive cells fluoresce red and localize mostly in the
nucleus while unoxidized DHE remains blue. Mean fluorescence intensities were
measured in various fields in triplicates and treatment effects were analysed using the
paired t-test and p<0.05 (*) was considered to be statistically significant.
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Inhibition of LPS-mediated NF-κ
κB(p65) nuclear translocation in Raw 264.7
murine macrophages by Didox.
The production of most inflammatory proteins is regulated through the NF-κB
pathway and the RT-PCR mRNA expression assay showed that Didox has an
effect on NF-κB expression. To define the molecular action by which Didox
affects NF-κB activation pathway in Raw 264.7 murine macrophages, the cells
were incubated with Didox (100 µM), LPS (0.1 µg/ml) or both for 24h and NF-κB
(p65) levels. NF-κB translocation was evaluated using immunofluorescence
microscopy by observing presence of p65 in cytosol or nuclei. More fluorescence
was observed in the cytosol than in nuclei of untreated and Didox treated Raw
264.7 murine macrophages whereas the reverse was observed in LPS-treated
cells (Fig 2.11). Didox also reduced p65 presence in nuclei since less
fluorescence was observed in nuclei of LPS-stimulated cells treated with 100 µM
Didox while more fluorescence occurred in the cytosol. The presence of more
p65 in cytosol of LPS-treated cells indicated that Didox inhibited translocation of
LPS-induced NF-κB nuclear translocation.
These results were confirmed using Western blot analysis which showed high
presence of p65 protein levels in LPS-treated cells than in Didox-treated cells
(Fig 2.12). The presence of high p65 protein levels in nuclei of cells stimulated
with LPS was diminished by co-treatment with 100 µM Didox indicating the
inhibitory action if Didox on LPS-mediated NF-κB nuclear translocation in Raw
cells.
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20 µm

Figure 2.11. Didox inhibits LPS-mediated NF-κB (p65) nuclear translocation in Raw
264.7 cells. Cells were incubated with LPS (0.1µg/ml) and/or Didox (100µM) for 24h and
NF-κB translocation was evaluated using immunofluorescence microscopy by observing
presence of p65 in cytosol or nuclei using FITC-labeled Ab. Cells were imaged using Nikon
AZ100 Epi-Fluorescent Microscope under FITC wavelength and mean fluorescence
intensities were measured in various fields in triplicates and treatment effects were
analysed using the paired t-test and p<0.05 (*) was considered to be statistically significant
compared to controls(unless otherwise indicated) . See complete image below in Fig 2.11b
with all fluorescence channels.
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Figure 2.11b. Complete view of NF-κB nuclear translocation immunofluorescence
in LPS-activated Raw 264.7 cells treated with Didox. The figure shows DAPI, DIC,
FITC channels and their merged images.
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Control

DX

LPS

DX+LPS

Figure 2.12. Didox inhibits LPS-mediated NF-κB (p65) nuclear translocation in Raw
264.7 cells. Cells were incubated with LPS (0.1µg/ml) and/or Didox (100µM) for 24h and
NF-κB translocation was evaluated using western blot analysis after extraction of
cytosolic and nuclear proteins.
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Didox inhibits LPS-mediated protein expression of iNOS, Cox-2 and TNF-α
in Raw 264.7 cells.
Among the target inflammatory genes regulated by NF-κB activation, iNOS, Cox2, and TNF-α are central to onset and progression of macrophage-mediated
inflammation. It was therefore essential to determine if Didox’s ability to inhibit
NF-κB activation can influence protein expression levels of iNOS, Cox-2 and
TNF-α. To achieve this goal Raw 264.7 macrophage protein expression levels of
iNOS, Cox-2 and TNF-α were evaluated using the Western blot analysis after 24
h of treatment with Didox (100 µM) in the presence or absence of LPS. Didox
suppressed LPS-mediated protein expression of iNOS, Cox-2 and TNF-α in Raw
264.7 macrophages after 24h (Fig 2.13). Supernatants from LPS-treated Raw
cells were very toxic to WEHI cells during the WEHI bioassay for TNF-α
production. Didox lowered this toxicity resulting in more WEHI survival since
supernatants from Didox-treated Raw cells showed a higher WEHI cell survival
compared to those from LPS-treated cells (Fig 2.13b).

Didox suppresses phagocytosis on FITC-labeled latex beads by LPS and
PMA activated Raw 264.7 murine macrophages
To evaluate the effect of Didox on macrophage functionality, cells were incubated
with FITC-labeled beads after treatment with Didox in the presence or absence of
LPS or PMA as outlined above. Efficiency of phagocytosis was determined by
using the phagocytosis index calculated as described above. Engulfment of
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beads increased with LPS priming while cells treated with Didox engulfed fewer
beads than untreated controls. Didox also reduced engulfment of FITC-labeled
latex beads in LPS- and PMA-treated Raw 264.7 as fewer latex beads were
internalized in Didox-treated cells (Fig 2.14).

Control

DX

LPS

DX+LPS

Figure 2.13. Didox inhibits LPS-mediated protein expression of iNOS, Cox-2 and
TNF-α in Raw 264.7 cells. Cells were incubated with LPS (0.1µg/ml) and/or Didox
(100µM) for 24h and iNOS, Cox-2, and TNF-α protein expressions were evaluated using
western blot analysis using β-actin house keeping gene to equalize loading.
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100 µm

Figure 2.13b. WEHI bioassay for TNF-α production confirms that Didox inhibits
LPS-mediated production of bioactive TNF-α in Raw 264.7 cells. Raw cells were
incubated with LPS (0.1µg/ml) and/or Didox (100µM) for 24h and supernatants were
collected for use (1:5 dilution) in treating WEHI cells for 24h. Cell survival was
determined by comparison with control cells.

80

Figure 2.14. Didox inhibits uptake of FITC-latex beads in LPS-stimulated Raw 264.7
cells. Cells were treated with Didox (100µM) or LPS (0.1µg/ml) and combination of both
for 1h. FITC-labeled beads were added to each well and bead-uptake was evaluated
using immunofluorescence microscopy and images were analyzed using Nikon AZ100
Epi-Fluorescent Microscope under FITC wavelength, DAPI wavelength, DIC-High and the
three were overlayed using the NIS-Elements Viewer 3.0 (Fig 2.14b below shows the
complete image with the 3 channels and overlays).
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Figure 2.14b. Complete view of FITC-labeled beads in Raw 264.7 cells using DAPI, DIC,
FITC channels, and their merged images.
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The effect of Didox on filamentous actin (F-actin) polymerization and
uptake of TRITC-labeled yeasts by Raw 264.7 murine macrophages.
Uptake and killing of microorganisms by professional phagocytes are dependent
on local, rapid remodeling of actin and immediately after ingestion phagosomes
are surrounded by a distinct rim of filamentous actin (F-actin). To evaluate the
Didox on this F-actin reorganization phenomenon and its role in phagocytosis,
cells were challenged with TRITC-labeled yeasts (S. cerevisiae) with concomitant
staining of F-actin using FITC-labeled phalloidin.

Cells were then fixed and

analyzed using epi-fluorescent and confocal microscope.

Although untreated

Raw macrophages engulfed more yeast cells, addition of Didox to untreated and
LPS-treated cells resulted with a significant decrease in yeast-uptake (Fig 2.15).
Staining of F-actin revealed that the actin cytoskeletal reorganization was robust
and extensive without Didox treatment and a rim of F-actin located around the
engulfed yeast particles. Although more extensions and striated villi were
observed in the absence of Didox than when Didox was added, the actin
cystoskeletal structure formation and organization was only slightly affected by
Didox.
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20 µm

50 µm

Figure 2.15. Didox inhibits uptake of TRITC-labeled yeasts by Raw 264.7
macrophages. Cells were seeded on coverslips in 6-well plates and incubated with
TRITC-labeled yeasts in presence or absence of Didox for 30 min.
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DISCUSSION
The use of non-steroidal anti-inflammatory drugs that possess intrinsic antiinflammatory and antioxidant properties while triggering the intracellular
cascades of protective pathways offers a promising strategy for therapeutic
applications in macrophage-mediated aberrant inflammation. An interesting
agent that might fulfill these criteria and inhibit excessive oxidative stress in
macrophages is the polyhydroxyphenyl hydroxamic acid derivative, Didox (N-3,4trihydroxybenzamide), which has been shown to possess antioxidant, oxygen
scavenging, and anti-inflammatory properties in a variety of experimental
systems. As a result, studies to explore the anti-inflammatory effects of Didox on
LPS-induced oxidative

stress

and

inflammation

in

Raw 264.7 murine

macrophages were a central focus area of this study. Didox comprise a new
class of antioxidants with ability to inhibit ribonucleotide reductase activity, act as
chelators of iron, and scavenge free radicals (Ding et al., 1992; Elford and Riet,
1989).

Didox was also previously shown to inhibit a preeminent inflammatory
transcription factor, NF-κB, probably due to their selective inhibition of
phosphorylation of the cytoplasmic inhibitor IκBα (Lee et al., 1997). Whether this
interesting molecule has other molecular effects that are potentially therapeutic is
unknown. It was therefore important to study the anti-inflammatory effect of Didox
in the LPS-stimulated Raw 264.7 murine macrophages and propose the
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molecular mechanism that could be involved in governing the resulting immunomodulatory effects.

The evaluation of Didox’s potential anti-inflammatory effects was carried-out
using the LPS-inducible Raw 246.7 murine macrophage model system. The Raw
264.7 murine macrophage cell line is most suitable for these studies because of
its morphological and functional similarity to human macrophage system. This
cell line is sensitive to LPS derived from gram-negative bacteria and thus
provides an inducible form of macrophages that undergo phagocytosis and
secrete lysozyme upon activation. This allows the evaluation of Didox on gene
profiles, morphological outlines, functional characteristics and inflammatory
behavior of macrophages in the activated and non-activated forms.

The first undertaking was to evaluate the cytotoxic effect of Didox on Raw 264.7
macrophages and find an optimal concentration of Didox suitable for modulating
the inflammatory behavior of Raw 264.7 murine macrophages. This was done by
subjecting Raw cells to increasing concentrations of Didox for 24h and
determining the cells’ viability profiles.

The MTT assay revealed that Didox

doses up to 100µM do not cause any significant reduction in cell death of Raw
264.7 macrophages and this was further confirmed by using the PI dye exclusion
assay and Flow cytometry assay using PI and Annexin-V. Together these set of
results show that both LPS (0.1µg/ml) and Didox (100µM) do not significantly
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inhibit cell proliferation or induce any form of cell death in Raw 264.7 murine
macrophages during 24h of treatment. Didox is known for its inhibitory role on
ribonucleotide reductase, an enzyme that catalyses the reduction of all four
ribonucleotides to deoxyribonucleotides for use in DNA synthesis. This RR
inhibitory property of Didox warrants an investigation into the potential cytostatic
action of this drug on Raw 264.7 cells. Differential interference contrast (DIC)
microscopic images were taken at 12h intervals for up to 48h to evaluate cell
growth profiles and colony formation after treating cells with LPS, Didox or in
combination. The cell growth profiles were not significantly affected by Didox or
LPS during the 48h period, suggesting that Didox does not exert a significantly
noticeable cytostatic action on these Raw cells.

There is a wide variety of genes and pathways that play a pivotal role in
regulation or generation of oxidative stress in activated macrophages; hence it
was therefore necessary to start by identifying the effect of Didox on expression
of genes associated with inflammation and oxidative stress in LPS-activated Raw
264.7 macrophages.

This was achieved through a multi-gene profiler array

system that assayed a total of more than 200 genes involved in Raw 264.7
inflammatory behavior. These PCR arrays are the most reliable tools for
analyzing the expression of a focused panel of genes with high reproducibility,
sensitivity and specificity. Raw 264.7 cells were treated with LPS, Didox, or
combination of both for 24h and mRNA isolated for gene expression studies and
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several oxidative stress and inflammation-related genes significantly affected by
Didox were indentified. Multigene profiling with real time PCR Array Profiler
revealed Didox-mediated inhibition of several inflammatory genes involved in
LPS-induced macrophage inflammatory activities and these included chemokines
(CCL2, CCL3, CCL4, CXCL10), IL-1, IL-6, TNF-α, iNOS, NADPH oxidase, GMCSF (Csf2), G-CSF (Csf3), Akt1, NF-κB (p105), and TLR4. Didox treatment also
resulted in increased mRNA gene expression of catalase, glutathione
peroxidase, and superoxide dismutase as determined by multigene superray
profiler. Once the effect of Didox on these genes was noticed, it was therefore
required to carry-out a PCR validation assay using specific primers targeting the
selected genes. The PCR validation assay confirmed that Didox suppressed
mRNA expression of IL-6, TNF-α, iNOS, Cox-2, p38α, p65, and p21.

Taking a closer look at these Didox-suppressed gene: TNF-α is known to be a
key mediator for the induction of apoptosis and development of humoral immune
response. However, at high concentrations, TNF-α has more pronounced
disadvantageous effects, such as inducing tissue injury, oxidative stress,
inflammation and potentiating septic shock (Shohami et al., 1999). Elevated
serum IL-6 levels have been observed in a number of pathological conditions,
including bacterial and viral infections, trauma, autoimmune diseases, and
inflammations (Hirano et al., 1994). iNOS catalyses the formation of NO, a highly
reactive free radical involved in a number of physiological and pathological
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processes.The role of NO is well established in the relaxation of vascular smooth
muscles, in the inhibition of mitogenesis and growth of glomerular mesangial
cells, and in macrophage toxicity. Under normal physiological conditions NO also
acts immunologically as a cytotoxic agent on invading microorganisms in
macrophages or on tumor cells. Oxidative stress and inflammatory responses in
activated Raw 264.7 cell line have been linked to increase in mRNA expressions
of inflammation-related genes such as IL-1, IL-6, TNF-α, iNOS, and COX-2
induced via the NF-κB pathway (Park and Park, 2009). Thus, it is well
documented that these above-mentioned Didox-suppressed genes play a pivotal
role in induction of cellular oxidative stress and inflammation in macrophages and
their inhibition opens possibilities for Didox as a regulator of oxidative stress and
inflammation.

IL-6 has often been linked to inflammatory as well as autoimmune diseases and
influences a plethora of cellular functions. IL-6 has also been well demonstrated
to be among the strong mediators of oxidative stress and has the potential to
alter redox equilibrium (Nussler et al., 1992, Chen et al., 1998, Desmarquest et
al., 1998). This prompted us to investigate the effect of Didox on production of IL6 in LPS-activated Raw 264.7 murine macrophages. Treatment of cells with
Didox led to a dose-dependent reduction of IL-6 secretion by LPS-stimulated
macrophages with maximal inhibition attained at 100 µM concentration of Didox.
These results correlated with the real-time PCR evaluation assays which showed
that Didox reduced LPS-mediated mRNA expression of IL-6. Didox could,
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therefore, be exerting its inhibitory effects on ROS generation via inhibition of IL6 production thereby reducing the LPS-induced inflammatory activity of Raw
264.7 murine macrophage cell lines.

Results from RT-PCR validation assays also confirmed that Didox-mediated
inhibition of inflammatory genes in LPS-activated Raw 264.7 macrophages was
accompanied by up-regulation

of

antioxidant enzymes:

catalase

(Cat),

glutathione peroxidase (Gpx), and superoxide dismutase (SOD). Since oxidative
stress is a result of a perturbed balance between ROS production and
antioxidant levels, the up-regulation of antioxidant pools with concomitant
inhibition of oxidative stress genes is very important in shifting the oxidative
stress status to the homeostatic stage.

Inhibition of iNOS mRNA expression warranted an investigation on iNOS activity
by determining if Didox inhibits NO secretion in LPS-stimulated Raw 264.7
murine macrophage cell line. Using the Griess assay it was shown that Didox
dose-dependently inhibits LPS-induced NO secretion. To further determine
intracellular NO production, a vital dye sensitive for NO was used to track NO
levels after treatment of LPS-activated Raw cells with Didox. DAF-2DA
fluorescence was robust in LPS-treated cells compared to untreated controls and
this NO sensitive fluorescence was ablated with addition of Didox, confirming the
ability of Didox to suppress intracellular NO production.
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Other ROS and RNS mediators that induced oxidative stress include H2O2,
superoxide radicals, and nitrogen peroxides. Evaluation of intracellular ROS
production using a fluorescein marker indicated that H2O2 increased with addition
of buthionine sulfoximine (BSO) or LPS. LPS induces its inflammatory actions in
macrophages via TLR4 while BSO is an inhibitor of the glutamatecysteinyl ligase
(GCL) enzyme and thus may exhibit a "pro-oxidative" action by depleting
glutathione pools. Didox inhibited both BSO and LPS-mediated intracellular H2O2
production and this was demonstrated via reduction of dichlorofluorescein (DCF)
fluorescence in Didox-treated Raw 264.7 cells. Accumulation of DCF indicates
the production of H2O2, a redox-active molecule (Bass et al., 1983, Royall and
Ischiropoulos, 1993). Reduction of fluorescence therefore suggests that Didox
inhibits H2O2 generation, an event that directly correlates with upregulation of
catalase mRNA expression and could suggest that Didox reduces H2O2 levels
either by upregulating catalase gene expression or activity. Didox upregulates
Gpx mRNA levels in Raw 264.7 cells and Gpx could also be responsible for
reduced H2O2 levels as it also catalyses the scavenging and decomposition of
H2O2 in these cells.

Since SOD mRNA levels were upregulated in Didox-treated Raw 264.7 cells and
SOD dismantles superoxide (O2●) radicals, it was necessary to assess the
production of intracellular O2● levels in LPS-activated Raw cells after treatment
with Didox.

Superoxide produced in cells was measured using the cell-
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permeable dye dihydroethidium (DHE), which mostly binds to nuclear DNA when
oxidized by superoxide and emits red fluorescence whereas the unoxidized DHE
emits blue fluorescence and remains localized mostly in the cytoplasm. DHE has
been specifically recommended for assessments of superoxide production in
cells because of its relatively high specificity (Zhao et al., 2003). A vigorous red
fluorescence was observed in LPS-treated Raw cells while Didox treatment
significantly reduced the red fluorescence during 24h incubation.

Further

addition of BSO, which depletes the GSH pools, exacerbated and increased
superoxide mediated fluorescence especially when this was combined with LPS
treatment of Raw cells. Didox rescued both BSO and LPS induced superoxide
production as shown by the resulting diminished red fluorescence post-treatment.
Potential implications of this reduction in intracellular detection and imaging of
superoxide by Didox in activated Raw cells is of significant importance since
superoxide radicals represent a highly reactive and cytotoxic group of free
radicals contributing to the generation of oxidative stress in inflammatory
diseases.

Several lines of evidence have revealed a requirement of ROS generation in NFκB activation and suggest that ROS production leads to site-directed NF-κB
oxidation resulting in increased NF-κB activation (Jaramillo et al., 2005, Jaramillo
and Olivier, 2002). Previous studies have also demonstrated that certain
antioxidants may block translocation of activated NF-κB complexes from the
cytoplasm to the nucleus, thus inhibiting NF-κB mediated gene activation (Bowie
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et al., 1997). LPS-stimulation of Raw cells leads to phosphorylation of NF-κB
dimers (p65/p50) in the cytoplasm. Upon phosporylation, the p65/p50 dimer
translocates from the cytoplasm to the nucleus and activates expression of target
inflammatory genes (including IL-6, TNF-α, iNOS, Cox-2) by binding to specific
promoter consensus sequences. We hypothesized that Didox-mediated inhibition
of LPS-induced inflammation in Raw 264.7 murine macrophages may be effected
via modifications on NF-κB activity or function. In order to test this hypothesis, we
examined nuclear localization of NF-κB complexes in Raw 264.7 murine
macrophages after LPS or Didox treatment using immunofluorescence
microscopy.

LPS stimulation of Raw 264.7 murine macrophages resulted in prompt
translocation of p65 from the cytoplasm to the nucleus. However, Didox
treatment counteracted this LPS-mediated p65 translocation since more p65 was
observed to be present mostly in the cytoplasm than in the nucleus of these
macrophages. The Didox-mediated inhibition of NF-κB translocation was
confirmed using a Western blot analysis which revealed higher p65 protein levels
in the nucleus after LPS-stimulation of Raw cells, whereas addition of Didox
lowered this LPS-induced nuclear p65 protein expression. This inhibition of NFκB nuclear translocation suggests an ability of Didox to suppress oxidative stress
induction in Raw 264.7 murine macrophages by inhibiting the NF-κB pathway.
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To determine the effect of Didox on Raw 264.7 murine macrophage functionality
a phagocytosis assay was carried out using FITC-labeled latex beads and
TRITC-labeled yeasts. To achieve this, we incubated Raw macrophages with
FITC-labeled latex beads in the presence of either LPS or Didox or both and
assessed the uptake of beads using immunofluorescence microscopy. Nonengulfed excess FITC-beads were washed and quenched with trypan blue to
ensure that the fluorescence observed only reflects those beads internalized by
macrophages. Most beads were internalized my macrophages after stimulation
with LPS alone but addition of Didox reduced this LPS-mediated bead uptake.
Although staining of F-actin in Raw 264.7 cells revealed that the actin
cytoskeletal reorganization was robust and extensive with LPS treatment and
vigorous extensions and nodules were observed in the absence of Didox than
when Didox was added, the influence of Didox on the actin cytoskeleton was not
strong enough to qualify it as a significant inhibition. There could be other
signaling events involved in the reorganization of F-actin since the effect of Didox
on the actin network at microscopic level is too subtle to make a clear conclusive
assessment.

CONCLUSION
In summary, we found that Didox inhibited LPS-induced oxidative stress, ROS
generation, IL-6 production, NO production, phagocytic activity, and NF-κB
nuclear translocation in Raw 264.7 murine macrophages. Due to its antioxidant
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characteristics, Didox might be used to prevent ROS-induced inflammatory
diseases such as sepsis-related injuries, cancer, fibrosis, emphysema, and
arthritis. More studies are needed to demonstrate its mechanism of action and
potential benefits in humans, however. Other studies done with clinical trials on
patients with advanced breast cancer treated with Didox at 6 g m-2 given by
intravenous infusion over 36 h every 3 weeks demonstrated minimal toxicity with
high drug clearance (Carmichael et al., 1990, Rubens et al., 1991). This shows
that Didox administration can be tolerated by patients with minimal side effects
and once its use in inflammation-based diseases is delineated, its application in
clinical settings can be achieved with relative rapidity.
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CHAPTER 3:
DIDOX MODULATES AHR LIGAND-INDUCED OXIDATIVE
STRESS, CYP1A1 INDUCTION, AND AHR-ACTIVITY IN RAW
264.7 MURINE MACROPHAGES.
ABSTRACT
Aryl hydrocarbon receptor (AHR) activation has been shown to induce oxidative
stress, various transcription factors, and subsequent inflammatory processes
mediating toxic and carcinogenic effects in vascular endothelial cells. Didox(3,4Dihydroxybenzohydroxamine) is a powerful synthetic antioxidant and one of the
most potent ribonucleotide reductase (RR) inhibitors, revealing an antitumor
effect in several experimental studies. To test the hypothesis that Didox can
modify AHR-mediated oxidative stress, Raw 264.7 murine macrophage cells
were treated with AHR ligands (PCB126, E804, IO) with or without Didox for 24h.
Didox strongly inhibited oxidative stress induced by PCB126 as measured by
DCF fluorescence.

The role of cytochrome P450 1A1 (CYP1A1) in the AHR ligand-induced toxicity
was investigated. Didox at 100 µM concentrations markedly inhibited CYP1A1
and AHR mRNA levels. Using immunofluorescence microscopy, Didox was
shown to significantly inhibit both AHR nuclear translocation and CYP1A1
expression in Raw 264.7 cells treated with these AHR ligands. Furthermore,
Didox downregulated reactive oxygen species production induced by PCB126,
E804, and IO in Raw 264.7 murine macrophages. These data suggest that
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oxidative stress regulatory effects of Didox may be useful in managing
inflammatory diseases initiated by exposure to AHR activating xenobiotics.

INTRODUCTION
Exposure to toxic polycyclic aromatic hydrocarbons produces oxidative stress
and raises a number of toxic and carcinogenic responses in experimental
animals and humans mediated for the most part by the aryl hydrocarbon – or
dioxin – receptor (AHR) (Meijer et al., 2007). The AHR is a ligand-activated
transcription factor whose central role in the induction of drug-metabolizing
enzymes has long been recognized. For quite some time now, it has become
clear that the AHR also functions in pathways outside of its role in detoxification
and that perturbation of these pathways by xenobiotic ligands may be an
important part of the toxicity of these compounds. The aryl hydrocarbon (dioxin)
receptor (AHR) is a cytosolic ligand-activated transcription factor that mediates
many toxic and carcinogenic effects in animals and possibly in humans (Barouki
et al., 2007).

It is generally accepted that its activation in vertebrates causes the toxic and
carcinogenic effects of a wide variety of environmental contaminants such as
dioxin (TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin), coplanar polychlorinated
biphenyls (PCBs) and polycyclic or halogenated aromatic hydrocarbons (PAHs or
HAHs). As a consequence of AHR activation, many detoxification genes are
transcriptionally induced, including those coding for the Phase I xenobiotic-
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metabolizing cytochrome P450 enzymes CYP1A1, CYP1A2, CYP1B1, and
CYP2S1, and the phase II enzymes UDP-glucuronosyl transferase UGT1A6,
NAD(P)H-dependent

quinone

oxydoreductase-1

NQO1,

the

aldehyde

dehydrogenase ALDH3A1, and several glutathione-S-transferases (Barouki et
al., 2007).

AHR is a member of the bHLH/PAS family of heterodimeric transcriptional
regulators (basic-region helix-loop-helix/Period [PER]-Aryl hydrocarbon receptor
nuclear translocator [ARNT]-single minded [SIM]) (Hoffman et al., 1991) involved
in regulation of development and in control of circadian rhythm, neurogenesis,
metabolism and stress response to hypoxia. Evidence from AHR knockout mice,
however, points to functions of the receptor beyond xenobiotic metabolism at
several physiologic roles that may contribute to the toxic response. Ablation of
the Ahr gene in mice leads to cardiovascular disease, hepatic fibrosis, reduced
liver size, spleen T-cell deficiency, dermal fibrosis, liver retinoid accumulation and
shortening of life span (reviewed in Barouki et al., 2007), suggesting that it has
biological functions other than xenobiotic detoxification that likely contribute to
the overall toxic response resulting from its activation.

The AHR is widely expressed in practically all mouse tissues (Abbott et al.,
1995), and in humans expression is high in lung, thymus, kidney and liver. In the
absence of ligand, the AHR exists as part of a cytosolic protein complex
containing two HSP90 chaperone molecules, the HSP90-interacting protein p23
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and the immunophilin-like protein XAP2

(Petrulis et al., 2003). Activation by

ligand is followed by translocation of the complex into the nucleus, dissociation
from the chaperone proteins and heterodimerization with ARNT. This AHR-ARNT
heterodimer interacts with several histone acetyltransferases and chromatin
remodeling factors and the resulting complex binds to consensus regulatory
sequences termed AHREs (aryl hydrocarbon response elements; also XREs or
DREs), located in the promoters of target genes, and by mechanisms not yet well
characterized, recruits RNA polymerase II to initiate transcription. The activated
AHR is quickly exported to the cytosol where it is degraded by the 26S
proteasome (Pollenz, 2002), hence preventing constitutive receptor activity.

Activation of the AHR by high-affinity HAH or PAH ligands results in a wide range
of cell cycle perturbations, including G0/G1 and G2/M arrest, diminished capacity
for DNA replication, and inhibition of cell proliferation. These alternative functions
of the AHR are often accomplished in the absence of an exogenous ligand, but
the underlying molecular mechanisms governing these processes remain elusive
in part because no definitive endogenous ligands have been identified (reviewed
in Puka et al., 2002). At present, all available evidence indicates that the AHR
can trigger signal transduction pathways involved in proliferation, differentiation
or apoptosis by mechanisms dependent on xenobiotic ligands or on endogenous
activities that may be ligand mediated or completely ligand independent. These
functions of the AHR coexist with its well-characterized toxicological functions
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involving the induction of Phase I and Phase II genes for the detoxification of
foreign compounds.

Polychlorinated

biphenyls

(PCBs)

are

widespread

persistent

residual

environmental contaminants and possess the ability to activate the AHR pathway
via binding to AHR. Some of

the PCBs, e.g. 3,3’,4,4’,5-pentachlorinated

biphenyls 126 (PCB126), have been demonstrated to produce extensive cellular
oxidative stress in vertebrates, including rodents (Fadhel et al., 2002) and human
hepatoma cells (Park et al., 1996). The antioxidant vitamin E has been shown to
have a protective effect against the gross morphological changes induced by
PCB126 exposure in zebrafish embryos (Na et al., 2009), indicating a potential
use of similar antioxidants in relieving oxidative stress induced by PCBs. PCB126 has been also shown to potentiate enhancement of plasma lysozyme levels
and increase Cyp1A1 induction in channel catfish, Ictalurus punctatus (Burton et
al., 2002; Rice and Roszell, 1998). The co-planar structure of PCB 126 allows it
to interact with AHR and activate subsequent AHR nuclear translocation.

Other molecules discovered to posess ability to bind AHR include indirubin and
indirubin-derivatives (Kawanishi et al., 2003). Indirubin derivatives such as
Indirubin-3’-(2,3 dihydroxypropyl)-oximether (E804) have been demonstrated to
block Stat3 signaling in human breast and prostate cancer cells via interactions
with AHR. Studies on AHR activation using indirubin derivatives demonstrated
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that although derivatives such as 6-Bromoindirubin-3’-monoxime (BIO) and 5Iodo-Indirubin-3’-monoxime (5-Iodo) bind to AHR and induce its nuclear
translocation, they also triggered ARNT-independent nuclear redistribution of
AHR (Knockaert et al., 2004). Indirubin-3-monoxime is an aryl hydrocarbon
receptor (AHR)-binding, idole-derived compound known to be a potent inducer of
CYP1A1, at least in hepatic cell lines and indirubin-3′-monoxime has been
demonstrated to either act as classical AHR ligand, or modulates endogenous
AhR-regulated activity in U937 histiocytic lymphoma cells (Springs and Rice,
2006).

These results demonstrate that indirubins and indirubin derivatives are potent
and functional ligands for AHR in living cells and that ARNT is not necessary for
indirubin-induced nuclear translocation of AHR. The discovery of the interaction
of indirubins with AHR opens the possibility that indirubins and indirubin
derivatives prevent cell proliferation and induce cellular oxidative stress via the
AHR pathway.

The persistence and prevalence of various exogenous AHR ligands in
environmental resources necessitates a search for molecules that can inhibit
AHR-mediated oxidative stress in an attempt to ameliorate AHR-induced disease
conditions outlined above. Although an AHR-mediated oxidative stress response
does not necessarily result in toxicity, it is a component in the mechanism of
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many toxic events that generate high amounts of ROS and RNS which ultimately
result in cellular stress, cell death or carcinogenesis. This is because AHR
regulates the expression of phase I and phase II detoxification enzymes that, by
the nature of their enzymatic activities, generate electrophilic reaction, which
cause oxidative stress, and conjugation reactions which attempt to combat it.
Therefore AHR activation results in a shift in the cellular redox balance,
suggesting a diverse and sophisticated phenomenon in oxidative stress response
and generation.

Since Vitamin E has shown potential oxidative stress inhibition capacity in
PCB126 induced AHR activation, similar antioxidants and NSAIDS such as Didox
can be evaluated for their ability to curb AHR-mediated oxidative stress. The
absence of endogenous ligands to AHR opens possibilities that AHR inhibitors
may be able to associate with AHR in various ways since endogenous ligands
may be using similar associations themselves. Didox is presented here as such
a potential AHR pathway inhibitor due to its well documented ability to scavenge
free radicals, block production of inflammatory cytokines, and reduce oxidative
stress in various experimental modules without inducing major side effects and
cytotoxicity. Its structural outlook may not permit binding to AHR but its activity
profiles may allow it to associate with AHR mediators and the AHR pathway in
various ways when acting as an antioxidant agent.
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MATERIALS AND METHODS

Materials
Indirubin derivatives and PCBs were obtained as follows: IO or Indirubin-3’monoxime (A.G. Scientific Inc., San Diego, CA), E804 or Indirubin-3’-(2,3
dihydroxypropyl) oximether (Alexis Biochemical, San Diego, CA), PCB126 or
3,3’,4,4’,5-pentachlorobiphenyl (Ultra Scientific, North Kingston, RI), and PCB104
or 2,4,6,2’,6’-pentachlorobiphenyl (Ultra Scientific, North Kingston, RI). Didox
was provided by Dr. Howard Elford, Molecules for Health Inc. (Richmond, VA)
and phorbol-12-mristate-13-acetate (PMA) was purchased from A.G. Scientific
Inc., San Diego, CA. LPS from E. coli serotype R515(Re) (ultra pure,
TLR4grade™) was purchased from Alexis biochemicals, San Diego, CA and FBS
from Atlas biological, Fort Collins, CO. DMEM, FBS, HEPES, glucose, sodium
bicarbonate, penicillin, streptomycin, paraformaldehyde, Triton X-100 , sodium
borohydride, buthionine sulfoximine and dimethyl sulfoxide (DMSO Hybri Max®)
were purchased from Sigma, St Louis, MO.

H2DCFA, DHE, DAF-2 DA (Molecular Probes, Eugene, OR) , rabbit anti-AHR
polyclonal antibody (Thermo Fisher Sci., Fremont, CA), goat-anti rabbit
polocylonal Ab, Raw 264.7 murine macrophage cells (ATCC®, Manassas, VA) ,
RT2 Profiler™ PCR Array System, RT2 First Strand Kit and RT2 qPCR Master
Mix were purchased from SABiosciences Corp., Frederick, MD, PCR primers
from IDT®, Coralville, IA, TRI-reagent® from Molecular Research Center,
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Inc.Cincinnati, OH and Halt™ Protease Inhibitor Cocktail from Thermo Fisher
Sci., Rockford, IL. All other chemicals were purchased from Sigma, St Louis, MO.

Cell Cultures
Murine macrophage RAW 264.7 cells were cultured in Dulbecco’s modified
Eagle’s medium (DMEM) containing 25 mM HEPES buffer, 3 g/L D-glucose, 1.5
g/L sodium bicarbonate and 4 mM L-glutamine. The culture media were
supplemented with 10% fetal bovine serum, penicillin (100 units/ml) and
streptomycin (100 µg/ml). All cultures were maintained in a humidified incubator
in 5% CO2 at 37 °C and cells were be split for sub-culturing two times a week.

Treatment Preparations
Didox (3,4-Dihydroxybenzohydroxamine) obtained was dissolved in dimethyl
sulfoxide (DMSO Hybri Max® purchased from Sigma, St Louis, MO) to a final
stock concentration of 200 mM and further diluted in culture medium to the
working serially diluted concentrations ranging from 3.12 – 200 µM. LPS (E. coli,
Serotype R515 ultra-pure, TLR4 gradeTM purchased from Alexis Biochemicals,
San Diego, CA) was diluted in serum-free culture medium before adding to
culture treatments. Indirubin derivatives and PCBs were also dissolved in DMSO
as stock solutions of 10-2 M.
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Flow Cytometry ApoScreen™ Annexin V Apoptosis Assay
Assessment of ability of AHR ligands, Didox or LPS to induced apoptosis in Raw
cells was carried out using AnnexinV/PI double staining. Apoptosis was
quantified by measurement of externalized phosphatidylserine residues as
detected using ApoScreen™ Annexin V Apoptosis Kit (Southern Biotech, AL,
USA). Raw 264.7 murine macrophages were seeded at 2.5 x 106 cells/well in 24well plates for 3hrs and treated with 10 µM of AHR ligands (PCB126, E804, IO)
or non-AHR ligands (PCB104) with or without Didox (100µM) for 24hrs. After
treatment cells were washed with ice-cold PBS and 500 µl of Annexin V binding
buffer. The binding buffer (100 µl) was replaced in all wells, 5 µl of Annexin VFITC was added, and the mixture was incubated for 15 min on ice with slow
shaker in the dark. Without washing, 380 µL of cold 1X binding buffer and 10 uL
of PI were added to each tube. After washing the samples, aliquots were
processed by flow cytometer using FACScanTM (BD Biosciences, San Jose, CA)
and 10,000 cells were scored in each event.

Fluorescence Microscopy Analysis of Cell death using Hoescht/PI staining
Cells were treated as indicated above on Lab-Tek® 8-chamber glass cultures
slides (Nalge Nunc Int., IL, USA) or Corning glass cover slips and Hoescht/PI
stain was added the cells for 15min. After washing off the dyes cells were
mounted using 50% glycerol (in PBS) with colorless nail polish sealing and
viewed under a fluorescent microscope.

105

Mouse Oxidative Stress Gene Analysis using RT2 ProfilerTM PCR-Arrays.
To search for candidate genes modulated by Didox after treatment of Raw cells
with PCB126, cells were seeded at 5 X 106 cells/ml in 75 cm2 culture flasks
(Corning Inc., NY) and allowed to adhere to flask surfaces to 3h. Cells were then
treated with PCB126 in the presence of absence of Didox (100 µM) and RNA
was extracted from cells after 24h using TRI-reagent® from Molecular Research
Center, Inc.(Cincinnati, OH) and retrotranscribed by RT-PCR first strant kit
(SuperArray Bioscience Corporation, Frederick, MD). Real-time PCR was
performed using the Mouse Oxidative Stress RT2 Profiler PCR Arrays and RT2
Real-Timer SyBR Green/qPCR Master Mix from SuperArray Bioscience
Corporation (Frederick, MD) on BioRad iQ5 real-time PCR detection system
(Applied Biosystems). For data analysis the ∆∆Ct method was used; for each
gene fold-changes were calculated as difference in gene expression between
untreated controls and treated cell cultures. A positive value indicates gene upregulation and a negative value indicates gene down-regulation.

AHR and Cyp1A1 Real-Time PCR assays
To evaluate the effect of AHR ligands (PCB126, E804, IO) on AHR and Cyp1A1
mRNA expression, RNA was extracted and cDNA obtained from treated murine
macrophages as mentioned above. mRNA levels were analysed by using the
following conditions: 1 cycle at 95°C for 10 min, 40 cycles at 95°C for 15 sec,
55°C for 1 min and quantified using primers listed in Table 3.1 below. The
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quantities of these mRNAs were expressed as fold-changes compared to the
untreated Raw 264.7 murine macrophage controls.

Table 3.1: Primer sequences used for RT-PCR validation of AHR and Cyp1A1 gene
expression in Raw 264.7 macrophages after treatment with AHR ligands.

Gene
AHR

CYP1A1

β-actin

Sequence
F: 5’-CTTTGCTGAACTCGGCTTGC-3’
R: 5’-TTGCTGGGGGCACACCATCT-3’
F: 5’-CCTCATGTACCTGGTAACCA-3’
R: 5’-AAGGATGAATGCCGGAAGGT-3’
F: 5'-TCATGAAGTGTGACGTTGACATCCGT-3'
R: 5'-CCTAGAAGCATTTGCGGTGCACGATG-3'
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Evaluation of AHR nuclear translocation using Immunofluorescence
Microscopy.
To assess AHR activity in Raw 264,7 murine macrophages, immunofluorescence
microscopy was use to monitor translocation of AHR from cytosol to nucleus after
potentially binding to AHR ligands. Raw 264.7 cells were cultured cells in 8chamber slides at 2 x105 cells/well and seeded for 3hrs followed by a 4h
treatment with 10 µM of AHR ligands (PCB126, E804, IO) or non-AHR ligands
(PCB104) with or without Didox (100µM). Cells were then fixed with 4% ρformaldehyde for 1hr and permeablized with 0.1% Triton X-100/1%BSA in PBS
for 30 min on a slow shaker. To quench out any residual fluorescence, cells were
treated with 0.01% sodium borohydride (in PBS) for 5 min and then incubated
with 1% BSA for 30 min to block non-specific binding sites. Cells were then
incubated for 1hr with rabbit anti-mouse AHR antibody followed by 1hr incubation
with FITC-labeled goat anti-rabbit IgG. The nuclei were stained with DAPI
addition for 5 minutes and cells were mounted on slides with coverslips using
50% glycerol in PBS. After sealing the edges with nail polish slides were viewed
under Nikon AZ100 epi-fluorescent microscope.

Assessment of CYP1A1 induction in Raw 264.7 cells using
Immunofluorescence Microscopy.
To assess CYP1A1 in Raw 264.7 murine macrophages after treatment with AHR
ligands, immunofluorescence microscopy was used.

Raw 264.7 cells were

cultured cells on coverslips at 2 x105 cells/well in 6-well culture plates and
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seeded for 3hrs followed by a 4h treatment with 10 µM of AHR ligands (PCB126,
E804, IO) or non-AHR ligands (PCB104) with or without Didox (100µM). Cells
were then fixed with 4% ρ-formaldehyde for 1hr and permeablized with 0.1%
Triton X-100/1%BSA in PBS for 30 min on a slow shaker. To quench out any
residual fluorescence, cells were treated with 0.01% sodium borohydride (in
PBS) for 5 min and then incubated with 1% BSA for 30 min to block non-specific
binding sites. Cells were then incubated for 1hr with rabbit anti-mouse CYP1A1
antibody followed by 1hr incubation with FITC-labeled goat anti-rabbit IgG. The
nuclei were stained with DAPI addition for 5 minutes and cells were mounted on
slides with coverslips using 50% glycerol in PBS. After sealing the edges with
nail polish slides were viewed under Nikon AZ100 epi-fluorescent microscope.

Evaluation of ROS production using fluorescent microscopy
Cells were seeded at 5 x 105 cells/well in eight chamber cell culture slides for 3h
and then treated with PCB126 (10 µM) in the presence or absence of Didox
(100µM). After 24h incubation, H2DCFA solution was added at 10-5 M to all wells
and incubated for an additional 30 min at 37˚C. The slides were washed twice
with PBS, fixed with 4% ρ-formaldehyde for 1hr and mounted using glycerol:PBS
(1:1) solution. The cover slip was placed over the mounting medium and the
slides were sealed using nail polish. The slides were viewed under the
fluorescence microscope and images capture using the digital camera.
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Assessment of intracellular superoxide radical production in Raw 264.7
cells
Superoxide production in Raw cells was assayed by using the oxidative
fluorescent dye DHE. DHE is oxidized on reaction with superoxide to ethidium
bromide, which mostly binds to DNA in the nucleus and fluoresces red. Cells
were seeded on cover slips at 2 x105 cells/well (in 6-well plates) for 3hrs. To
quench out any residual fluorescence, cells were treated with 0.01% sodium
borohydride (in PBS) for 5 min. After loading cells with 10 µM DHE for 15min,
cells were treated for 120 min with 1 µM of AHR ligands (PCB126, E804, IO) or
non-AHR ligands (PCB104) with or without Didox (100µM). Cells were fixed and
mounted on slides and analyzed using the Nikon AZ100 epi-fluorescent
microscope. The un-oxidized DHE remains blue (λEx\Em =355\420nm) while the
oxidized DHE fluoresces red (λEx\Em=355\420nm). Images were captured using
the NIS-Elements Viewer 3.0.

Statistical Analysis
All experiments are representative of three repeats carried out in triplicates and
the error bars represent the standard deviation from the mean average. All data
representations were analyzed using Graphpad PRISM 4.0 (Graphpad, San
Diego, CA, USA) or Sigmaplot (SPSS). Treatment effects were analysed using
the paired t-test and p<0.05 was considered to be statistically significant.
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RESULTS

Flow Cytometry ApoScreen™ Annexin V Apoptosis Assay
An apoptosis assay was carried out using AnnexinV/PI double staining and flow
cytometry to assess cytotoxic potential of AHR ligands (PCB126, E804, BIO, IO),
Didox or LPS in Raw 264.7 murine macrophages. None of the cells groups
treated with Didox, LPS or AHR ligands showed significant signs of cell death or
apoptosis (Fig 3.1). Cells which stained positive Annexin-V/PI were generally
less than 1% in all cases investigated. Thus, almost all treated cells excluded PI
stain and stained negative for Annexin V. The exclusion of PI and negative
staining of Annexin-V allowed further exploration of action these drugs knowing
that they are not cytotoxic to Raw cells at the concentrations tested.

Fluorescence Microscopy Analysis of Cell death using Hoescht/PI staining
Hoechst 33342, a type of blue-fluorescence dye (excitation/emission maxima
≈350/461 nm when bound to DNA), stains the condensed chromatin in apoptotic
cells more brightly than normal chromatin. Propidium iodide (PI), a redfluorescence dye (excitation/emission maxima ≈535/617 nm when bound to
DNA), is only permeant to dead cells. The staining pattern resulting from the
simultaneous use of these dyes makes it possible to distinguish normal,
apoptotic, and dead cell populations by fluorescence microscopy. Cells were
treated with Didox or AHR ligands and stained with Hoechst/PI double stain.
Fluorescent microscope images confirmed that none of the drugs induced
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apoptosis or cell death since all Raw 264.7 cells excluded PI stain and only
accepted the Hoechst stain (Fig 3.2).
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Figure 3.1. Flow cytometric analysis of Raw 264.7 cells treated with Didox, LPS
and AHR-ligands(PCB126, E804, IO and BIO). Raw 264.7 murine macrophages were
seeded in 24 well plates for 3hrs and treated with 10 µM of AHR ligands (PCB126, E804,
IO), LPS (0.1 µg/ml) or Didox (100µM) for 24hrs.

Apoptosis was quantified by

measurement of externalized phosphatidylserine residues as detected by flow cytometer
and 10 000 cells were scored in each event.
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Figure 3.2. Hoechst/PI apoptosis evaluation of Raw 264.7 cells treated with AHR
ligands (PCB126, E804, IO) and Didox. Cells were treated as indicated above,
Hoescht/PI stain was added the and cells were viewed under a fluorescent microscope
after fixing and mounting on glass slide.

50 µm
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Evaluation of AHR nuclear translocation using Immunofluorescence
Microscopy.
The induction AHR ligands mediated oxidative stress in many cells occurs via
binding to the the aryl hydrocarbon receptor (AHR) and activating the AHR
pathway. The inactive form of the AHR molecule resides in the cytoplasm and
upon binding to AHR ligands it translocates to the nucleus to induce targeted
expression of responsive genes. To assess AHR nuclear translocation after
binding AHR ligands (PCB126, E804, IO) in Raw 264.7 murine macrophages,
immunofluorescence microscopy was used. All AHR ligands used were able to
induce AHR nuclear translocation with PCB126 and E804 inducing higher levels
of nuclear translocation as evidence by lesser AHR in cytoplasm and more
fluorescence in the nucleus (Fig 3.3). The AHR ligands induced translocation
was evidently suppressed by addition of Didox since lower nuclear AHR
fluorescence was observed upon its addition. PCB104 is not an AHR ligand and
was employed as a negative control to ensure specificity of AHR ligands to AHR
binding.
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Figure 3.3. The effect of Didox on PCB126, E804, and IO-induced AHR nuclear
translocation in Raw 264.7 murine macrophages. Raw 264,7 cells were treated
with AHR ligands in the presence or absence of Didox and immunofluorescence
microscopy was used to monitor translocation of AHR from cytosol to nucleus (bars =
20 µm)
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Assessment of CYP1A1 induction in Raw 264.7 cells using Immunofluorescence Microscopy.
Induction of Cyp1A1 is known to represent a significant event in the toxicity of
AHR ligands and the Cyp1A1 gene provides a model system for studying the
mechanism of gene transcription by AHR. Therefore expression of Cyp1A1 after
AHR activation is indicative of activation of the AHR pathway and further
confirms binding of AHR ligands to AHR. To assess CYP1A1 activity in Raw
264,7 murine macrophages after treatment with candidate AHR ligands
(PCB126, E804, IO), immunofluorescence microscopy was used. PCB126 and
E804 consistently induced higher Cyp1A1 expression as evidenced by higher
fluorescence in Raw cells after treatment (Fig 3.4 and 3.4b).

IO also induced Cyp1A1 expression albeit at lower levels than PCB126 and
E804. The expression of Cyp1A1 induced these AHR ligands was variably
inhibited by addition of Didox and lower fluorescence was observed in the Raw
cells when Didox was included in the regimen. PCB104 is not an AHR ligand and
as expected did not induce Cyp1A1 expression in Raw cells.
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100 µm

Figure 3.4. The effect of Didox on CYP1A1 induction by AHR ligands (PCB126,
E804, and IO) in Raw 264.7 murine macrophages. Raw 264.7 cells were cultured
cells in 6-well culture plates and treated with 10 µM of AHR ligands (PCB126, E804, IO)
or non-AHR ligands (PCB104) with or without Didox (100µM). CYP1A1 antibody was
measure using FITC-labeled goat anti-rabbit IgG and nuclei were stained with DAPI.
Slides were viewed under Nikon AZ100 Epi-Fluorescent Microscope.
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Figure 3.4b. Qunatitative analysis of the effect of Didox on CYP1A1 induction by
AHR ligands (PCB126, E804, IO) in Raw 264.7 murine macrophages. Raw 264.7
cells were cultured cells in 6-well culture plates and treated with 10 µM of AHR ligands
(PCB126, E804, IO) or non-AHR ligands (PCB104) with or without Didox (100µM).
CYP1A1 antibody was measure using FITC-labeled goat anti-rabbit IgG and nuclei were
stained with DAPI. Slides were viewed under Nikon AZ100 Epi-Fluorescent Microscope.
Mean fluorescence intensities were measured in various fields in triplicates and
treatment effects were analysed using the paired t-test and p<0.05 (*) was considered to
be statistically significant.
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AHR and Cyp1a1 Gene expression using Real-Time PCR
Real-time PCR using specific AHR and CYP1A1 primers was carried out to
evaluate the effect of AHR ligands (PCB126, E804, IO) on AHR and Cyp1A1
mRNA expression in Raw 264.7 murine macrophages. PCB126 induced the
highest mRNA expression of more than 60-fold above the controls followed by
E804 with a 24-fold change and IO with less than 10-fold difference (Fig 3.5).
This AHR ligand-induced mRNA expression was significantly suppressed by
addition of Didox. Thus, Didox inhibited mRNA expression levels of AHR and
Cyp1A1 in Raw 264.7 murine macrophages treated with PCB126, E804 and IO.

Mouse Oxidative Stress Gene Analysis using RT2 ProfilerTM PCR-Arrays.
Once it was established that these AHR ligands (at 10 µM) do not induce cell
death while inducing AHR and Cyp1A1 activity in Raw 264.7 cells, a search for
oxidative stress related candidate genes was carried out using PCB126, a more
potent AHR ligand. The Mouse Oxidative Stress RT2 ProfilerTM PCR-Arrays
revealed that expression of several genes playing important roles in induction of
oxidative stress in macrophages were significantly attenuated upon addition of
PCB126 (Table 3.2). Of these, genes of the NADPH oxidase family were notably
induced whereas most antioxidant genes such as catalase, glutathione
peroxidases,

peroxiredoxins

and

superoxide

dismutases,

were

variably

suppressed upon addition of PCB126 in Raw 264.7 cells. Addition of Didox
suppressed PCB126-induced expression of NADPH oxidases while inducing

120

expression of antioxidant genes (Catalase, glutathione peroxidase, superoxide
dismutase, and peroxiredoxins) in Raw 264.7 cells.
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Figure 3.5. The effect of Didox and LPS on AHR and CYP1A1 mRNA
expression in Raw 264.7 cells (Real-time PCR study with specific primers).

To evaluate the effect of AHR ligands (PCB126, E804, IO) on AHR and Cyp1a1
mRNA expression, RNA was extracted and cDNA obtained from treated murine
macrophages to run a real-time PCR assay as mentioned in methods above.
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Table 3.2. Real-time PCR multigene Array for evaluation of mouse
oxidative stress related genes in Raw 264. 7 cells after treatment with
PCB126 in presence or absence of Didox. For data analysis the ∆∆Ct

method was used; for each gene fold-changes were calculated as difference in
gene expression between untreated controls and treated cell cultures. A
positive value indicates gene up-regulation and a negative value indicates
gene down-regulation.
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Didox inhibits PCB126-induced ROS production in Raw cells

Intracellular ROS production in Raw 264.7 cells was measured using 5-(and-6)chloromethyl-2',7'-dichlorodihydrofluorescein diacetate (CM-H2DCFDA) which is
hydrolyzed to DCFH in the cell, and DCFH is oxidized to form highly fluorescent
DCF in the presence of the correct oxidant. ROS generation was detected as a
result of DCFH oxidation after addition of PCB126 in Raw 264.7 cells and this
was indicated by higher fluorescence in the cells upon treatment (Fig 3.6 and
3.6b). The resulting fluorescence was subdued by co-incubation with Didox to
indicate suppression of PCB126-induced ROS production.
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Figure 3.6. Didox inhibits ROS production in Raw 264.7 cells treated with PCB126.
Cells were seeded at 5 x 10

5

cells/well in eight chamber cell culture slides for 3h and

then treated with PCB126 (10 µM) in the presence or absence of Didox (100µM).
H2DCFA solution was added at 10-5M to all wells and incubated for an additional 30 min
at 37˚C. The slides were viewed under the fluorescence microscope and images capture
using the digital camera.
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Figure 3.6b. Quantitative assessment of ROS production in Raw 264.7 cells
treated with PCB126 and Didox. Cells were seeded at 5 x 10

5

cells/well in eight

chamber cell culture slides for 3h and then treated with PCB126 (10 µM) in the presence
or absence of Didox (100µM). H2DCFA solution was added at 10-5M to all wells and
incubated for an additional 30 min at 37˚C. The slides were viewed under the
fluorescence microscope and images capture using the digital camera. Mean
fluorescence intensities were measured in various fields in triplicates and treatment
effects were analysed using the paired t-test and p<0.05 (*) was considered to be
statistically significant.
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Assessment of intracellular superoxide radical production in Raw 264.7
cells

Of the ROS molecules produced by macrophages during inflammation,
superoxides are in the most reactive catergory. DHE, a vital dye sensitive to
superoxide oxidation, was employed to detect superoxide production in Raw cells
after treatment with PCB126 and E804 and to determine if this production can be
attenuated by Didox. An intense red fluorescence was observed upon treatment
of cells with PCB126 and E804 to indicate a robust production of intracellular
superoxide radicals in Raw 264.7 cells (Fig 3.7 and 3.7b). This robust red
fluorescence was significantly reduced by addition of Didox in these cells. The
unoxidized DHE maintained a blue fluorescence in all culture treatments.
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Figure 3.7. Didox inhibits PCB126 and E804-induced oxidative burst and
intracellular superoxide production in Raw 264.7 cells. Cells were loaded with 10 µM
DHE for 15min, and treated for 120 min with 10 µM of AHR ligands (PCB126 and E804)
or non-AHR ligands (PCB104) with or without Didox (100µM). Slides were analyzed
using the Nikon AZ100 Epi-Fluorescent Microscope (Bar = 20 µm).
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Figure 3.7b. Quantitative analysis of oxidative burst and intracellular superoxide
production in Raw 264.7 cells treated Didox, PCB126 and E804. Cells were loaded
with 10 µM DHE for 15min, and treated for 120 min with 10 µM of AHR ligands (PCB126
and E804) with or without Didox (100µM). Slides were analyzed using the Nikon AZ100
Epi-Fluorescent Microscope. Mean fluorescence intensities were measured in various
fields in triplicates and treatment effects were analysed using the paired t-test and
p<0.05 (*) was considered to be statistically significant (compared to control unless
otherwise indicated).
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DISCUSSION

The aryl hydrocarbon receptor (AHR) is a ligand activated transcription factor that
regulates genes involved in xenobiotic metabolism, cell proliferation, and
differentiation (Meijer et al., 2007). There have been many reports about toxic
mechanisms of AHR ligands or xenobiotics capable of activating the AHR
pathway and they demonstrated the relationship between oxidative stress and
the site of target organs. Certain PCBs can compromise normal functions of
vascular endothelial cells by activating oxidative stress-sensitive signaling
pathways and subsequent proinflammatory events critical in the pathology of
atherosclerosis and cardiovascular disease (Henning et al., 2002). However,
there are some reports about the protective effects of some antioxidants against
AHR ligands in cell culture systems with vitamin E being shown to protect against
neurotoxicity caused by Aroclor1254 or PBC-induced toxicity if zebrafish
embryos (Na et al., 2009).

Thus, it was worthwhile to investigate the ability of Didox to inhibit the AHR
pathway in Raw 264.7 murine macrophages since it has been demonstrated to
be a powerful antioxidant in various experimental models. Raw 264.7 murine
macrophages were selected as a preferred model for this study since
macrophages play an active role in oxidative stress mediated diseases and also
express AHR along with associated molecules of the AHT pathway. Several AHR
ligands were identified and used as candidates for use in the study, and this
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include PCB126, E804, and IO whereas a non-AHR binding molecule, PCB104,
was used to ensure specificity of reactions.

Since AHR ligands can induce lethal toxicity in macrophages, it was important to
first evaluate the cytotoxic profiles of these candidate ligands and their ability to
induce apoptosis in Raw 264.7 macrophages. Using the Annexin-V/PI flow
cytometry assay and Hoechst/PI apoptosis assay, it is clearly demonstrated here
that none of the AHR ligands induced apoptosis in these Raw macrophages
when used at 10 µM concentration for 24h. More than 98% of the Raw 264.7
cells remained viable and showed no noticeable signs of apoptosis after
treatment with PCB126, E804, or IO. Cells mostly stained negative for Annexin-V
and excluded PI while staining positive for the cell permeant, Hoechst 33342. It
was therefore concluded that these doses can be safely used for evaluating AHR
pathway associated responses in these cells line for durations up to 24h without
cell death induction.

The next step was to evaluate if these candidate xenobiotics can bind to AHR
and induce its translocation from the cytosol to the nucleus. Previous studies
using urine of healthy individuals as a starting biological material to identify AHR
ligands recognized indigo and indirubins as potent AHR activators. Hence,
indirubin derivatives such as E804 and IO were evaluated for the ability to bind
AHR in Raw 264.7 murine macrophages. PCB126 has been well demonstrated
to strongly activate AHR pathways in various developmental model systems and
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its ability to activate AHR reactions in Raw 264.7 cells was also evaluated.
Evaluation of AHR nuclear translocation using immunofluorescence microscopy
showed that all the AHR ligands tested were able to induce movement of AHR
from cytosol to the nucleus. PCB126 and E804 were shown to be more potent
AHR activators compared to IO. Addition of Didox to these treatments resulted in
lower AHR nuclear translocation and this indicated that Didox suppressed AHR
activation mediated by PCB126, E804, and IO. PCB104 failed to induce nuclear
translocation of AHR and this demonstrated the AHR binding specificity of the
AHR ligands used. The absence of an identifiable endogenous AHR ligand has
led to possibilities that AHR activation can be activated via association to AHR in
ways other than direct AHR binding. To this effect, an antioxidant such as vitamin
E has been subsequently shown to protect against gross morphological changes
induced by PCB126 (Meijer et al., 2007). It is therefore possible that an
antioxidant like Didox could be using related inhibitory features to suppress AHR
binding of PCB126, E804, and IO in Raw 264.7 cells.

Activation of AHR leads to enhanced expression of a variety of genes and the
most prominent of these is cytochrome P450 (CYP1A1), playing a major role in
generating subsequent oxidative stress responses (Knockaert et al., 2004). Since
PCB126, E804, and IO were shown to bind AHR in Raw 264.7 cells their ability
to induce CYP1A1 expression was assessed. Immunofluorescence microscopy
analysis of Raw 264.7 cells treated with these AHR ligands revealed a higher
expression of CYP1A1 in these cells compared to untreated and PCB104 treated
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controls. A more pronounced CYP1A1 expression was noticeable in PCB126 and
E804 treated cells compared to IO-treated samples. Interestingly, these results
correlate positively with AHR binding studies which revealed that PCB126 and
E804 induced higher AHR nuclear translocation in Raw 264.7 cells compared to
those treated with IO. When Didox was added to the treatment regimen
containing these AHR ligands, CYP1A1 expression was significantly suppressed.
These results suggest an inhibitory role of Didox against AHR activation and
subsequent CYP1A1 expression in Raw 264.7 murine macrophages. Gene
expression studies using Real-time PCR revealed that Didox inhibited PCB126-,
E804-, and IO-induced AHR and CYP1A1 mRNA expression in Raw 264.7
macrophages. Didox might therefore be inhibiting AHR activation via suppression
of both mRNA and protein expression of AHR and CYP1A1.

AHR activation has been shown to be accompanied by high levels of oxidative
stress and production of reactive oxygen species in various cell culture and
animal systems. A search for oxidative stress response genes was carried out to
identify genes that may targets for PCB126 induced activation in Raw 264.7
murine macrophages. A mouse oxidative stress real-time PCR array was carried
to evaluate 84 oxidative stress and cytotoxicity related genes in Raw 264.7
murine macrophages. PCB126 strongly increased mRNA expression of NADPH
oxidase 1 and 4, NADPH oxidase activator, NADPH organizer and Parkinson
disease 7 gene in raw cells. NADPH oxidase of phagocytes plays a crucial role in
host defense by generating an oxidative burst and producing reactive oxygen
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species (ROS) that are intended to kill invading microbes (Rada et al., 2004).
Didox addition, however, lowered PCB126-induced mRNA expression of these
NADPH oxidase family members as indicated by lowered fold changes when
Didox was included in the treatments. Moreover, Didox increased expression of
genes such as catalase, glutathione peroxidase, peroxiredoxin and superoxide
dismutase. Catalase play a central role in the decomposition of hydrogen
peroxide and, together with glutathione peroxidases and peroxiredoxins, form the
highly efficient machinery for detoxifying cells by reducing hydrogen peroxide
levels. Superoxide dismutases are very efficient at reducing the levels of highly
reactive superoxide free radical. The increase in mRNA expression of this family
of genes by Didox suggests an important role of Didox as an antioxidant
molecule in Raw 264.7 murine macrophages against PCB126.

Due to the changes observed in profiles of antioxidant genes as effect by Didox,
it therefore was necessary to further evaluate intracellular ROS production and
reactive oxidative burst in Raw 264.7 after treatment with AHR ligands. ROS
generation immunofluorescence assay using oxidation of DCFH to DCF revealed
an increased intracellular ROS production in Raw 264.7 cells treated with
PCB126, a more potent AHR activator. This PCB126-mediated ROS production
was lowered by addition Didox. The reduction of PCB126-induced ROS
production by Didox correlates with earlier RT-PCR gene expression which
showed increased catalase expression. Hydrogen peroxide is mainly responsible
for ROS production detected through DCFH system and since it is decomposed
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by catalase-mediated catalysis, Didox-uprelugation of catalase gene expression
could be mainly responsible for the observed ROS suppression in Raw 264.7
macrophages.

Assessment of superoxide radical production in Raw 264.7 murine macrophages
treated with AHR ligands was achieved using the DHE system which is highly
sensitive to superoxide oxidation and emits a strong red fluorescence upon
contact. A robust red fluorescence indicative of oxidative burst and increased
superoxide production was observed when cells were treated with PCB126 and
E804. IO also increased superoxide production compared to untreated and
PCB104 controls. Intracellular superoxide production was strongly reduced by
addition Didox in all treatments of Raw macrophages with AHR ligands. These
results were however not surprising since Didox was earlier shown to increase
expression of superoxide dismutase, an enzyme responsible for neutralizing
superoxide radicals.
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CONCLUSION

Dysfunction and aberrant activation of macrophages is a critical underlying cause
of the initiation of cardiovascular, neurodegenerative and inflammatory diseases.
In

addition

to

macrophage

dysfunction,

another

functional

change

in

cardiovascular and neurodegenerative diseases is the activation of the
endothelium that is manifested as an increase in the production of oxidative
stress related molecules. These high levels of reactive oxygen molecules, along
with cytokines and adhesion molecules, are proposed to mediate the
inflammatory aspects of degenerative disease by regulating the entry of
leukocytes, both macrophages and lymphocytes, into the vascular wall.

There is evidence that the CYP1A1 subfamily is present in most and possibly all
animal and human systems, including macrophages. For example, CYP1A1 has
been detected in endothelial linings of fish and rodents, as well as in cultured
human and porcine endothelial cells (Smolowitz et al., 1992; Stegeman et al.,
1995; Toborek et al., 1995; Celander et al., 1997; Zhao et al., 1998; Hennig et
al., 1999; Annas et al., 2000; Schlezinger and Stegeman, 2001). Oxidative stress
and increased CYP1A1 expression can be induced via There is increasing
evidence that exposure to polycyclic aromatic hydrocarbons can lead to
cardiovascular toxicity and atherosclerosis. For example, there was a significant
increase in mortality from cardiovascular diseases among Swedish capacitor
manufacturing workers exposed to PCBs for at least 5 years (Gustavsson and
Hogstedt, 1997), and most excess deaths were due to cardiovascular disease in
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power workers exposed to phenoxy herbicides and PCBs in waste transformer oil
(Hay and Tarrel, 1997).

The ability of Didox to downregulate AHR-mediated activation therefore presents
an antioxidant system that can reduce AHR-mediated oxidative stress and
cellular toxicity in macrophages. Didox has also been shown to potently inhibit
NF-κB activation in various experimental models. Earlier work by Henning’s Lab
indicates that coplanar PCBs that function as AhR agonists may be
proinflammatory by activating NF-κB in vascular endothelial cells (Henning et al.,
2002) and that this resultant oxidative stress can play a critical role in observed
PCB-mediated endothelial cell dysfunction (Hennig et al., 1996). The ability of
Didox to inhibit NF-κB and AHR activation provides a non-steroid antiinflammatory drug that may be used as a potential treatment in disease
conditions mediated by polycyclic aromatic aromatic hydrocarbons.
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OVERALL CONCLUSION

In this study, Didox has been demonstrated to block inflammation and oxidative
stress induced by LPS and AHR ligands in Raw 264.7 murine macrophages.
These results present Didox as a novel therapeutic compound that may block
oxidative

stress

and

treat

inflammation-based

diseases

by

regulating

macrophage activity. The ability of Didox to inhibit oxidative stress and regulate
macrophage activity compliments its ribonucleotide reductase inhibitory capacity.
The multifaceted behavior of Didox arms it with numerous target point in treating
ailments exacerbated by deregulated macrophage activation. This is because
macrophages undergo a wide spectrum of polarized activation states and have
the dual potential to elicit tissue destructive reactions and to promote tumor
progression. In general, tumor-associated macrophages from established tumors
and the related myeloid-derived suppressor cells help cancer progression and
metastasis. Therefore, these types of destructive macrophages are a key
component of pathways connecting inflammation and cancer. Didox has the
ability to inhibit cancer growth due to its ribonucleotide reductase inhibitory
potential and by demonstrating its ability to inhibit inflammation or suppress
oxidative stress presents it with two important target points: cell division and
inflammation.

In this study Didox has been demonstrated to inhibit production of TNF-α, Cox-2,
NO, ROS, and IL-6. TNF-α and IL-6 are two of the major inflammatory cytokines
targeted for therapeutic treatment of inflammation based disease conditions and
the ability of Didox to suppress their production is of paramount importance. Cox2 is an enzyme that mediates production of prostaglandins responsible for
inflammation and pain. Cox-2 inhibitors have been sought after for decades to
alleviate inflammation and pain caused by high Cox-2 expression. By exhibiting
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Cox-2 inhibitory abilities, Didox provides a promising NSAID that can be used to
block inflammation and pain associated with high levels of Cox-2. The most
important aspect of Didox is its ability to upregulate gene expression of
antioxidants such catalase, thioredoxins, superoxide dismutase, and glutathione
peroxidase. This upregulation of antioxidants is most probably responsible for the
reduction in ROS production observe upon treatment of LPS- or AHR-induced
Raw 264.7 cells with Didox. NF-κB and AHR can be activated by presence of
high reactive oxygen intermediates. Thus, the suppression of ROS production by
Didox may be responsible for its inhibitory effect on NF-κB or AHR. NF-κB and
AHR are redox sensors and by depleting the cellular ROS pool Didox might be
indirectly suppressing NF-κB and AHR activation along with associated
cytotoxicities. Further studies can be designed to determine if Didox directly
binds NF-κB and AHR or whether their inhibition is through indirect association.
Using an appropriate inflammation model system animal studies can be carried
to determine if the inflammation and oxidative stress inhibitory potential of Didox
shown in Raw 264.7 murine macrophages can be sustained in an in vivo system
and to further determine if this drug carries other physiologically rewarding
properties.

Chronic

inflammation

caused

by

aberrant

macrophage

activation

and

environmental contaminants such as those that activate the AHR pathway or NFκB pathway play a pivotal role in pathogenesis of most diseases. Administered
alone or in combination with other drugs that inhibit similar pathways, Didox
provides a more effective candidate which can regulate oxidative stress and
inflammation while boosting recovery and enhancing improved disease-free
survival.
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